FDA902a FDA Standard Frozen Tissue Array, for therapeutic and diagnostic antibody validation for FDA approval, total 30 organs, 3 individual donors per organ, spanning two frozen tissue microarray slides, rep US Biomax 1206 |
FDA902a |
FDA Standard Frozen Tissue Array, for therapeutic and diagnostic antibody validation for FDA approval, total 30 organs, 3 individual donors per organ, spanning two frozen tissue microarray slides, rep |
US Biomax |
|
1206€ |
|
Pub |
FDA901 FDA Standard Frozen Tissue Array, for therapeutic and diagnostic antibody validation for FDA approval, total 30 organs, 3 individual donors per organ, spanning two frozen tissue microarray slides.; ih US Biomax 1438 |
FDA901 |
FDA Standard Frozen Tissue Array, for therapeutic and diagnostic antibody validation for FDA approval, total 30 organs, 3 individual donors per organ, spanning two frozen tissue microarray slides.; ih |
US Biomax |
|
1438€ |
|
Pub |
FDA901-2 FDA Standard Frozen Tissue Array, for therapeutic and diagnostic antibody validation for FDA approval, total 30 organs, 3 individual donors per organ. (slide two); ihc Anti-Actin confirmed US Biomax 858 |
FDA901-2 |
FDA Standard Frozen Tissue Array, for therapeutic and diagnostic antibody validation for FDA approval, total 30 organs, 3 individual donors per organ. (slide two); ihc Anti-Actin confirmed |
US Biomax |
|
858€ |
|
Pub |
FDA901-1 FDA Standard Frozen Tissue Array, for therapeutic and diagnostic antibody validation for FDA approval, total 30 organs, 3 individual donors per organ. (slide one); ihc Anti-Actin confirmed US Biomax 858 |
FDA901-1 |
FDA Standard Frozen Tissue Array, for therapeutic and diagnostic antibody validation for FDA approval, total 30 organs, 3 individual donors per organ. (slide one); ihc Anti-Actin confirmed |
US Biomax |
|
858€ |
|
Pub |
FDA902b FDA Standard Frozen Tissue Array (2 slide set), for therapeutic and diagnostic monoclonal antibody validation recommanded by FDA, 90 tissue cores of 30 organs, 3 individual donors per organ, replacing US Biomax 1206 |
FDA902b |
FDA Standard Frozen Tissue Array (2 slide set), for therapeutic and diagnostic monoclonal antibody validation recommanded by FDA, 90 tissue cores of 30 organs, 3 individual donors per organ, replacing |
US Biomax |
|
1206€ |
|
Pub |
FDA902-2 FDA Standard Frozen Tissue Array, for therapeutic and diagnostic antibody validation for FDA approval, 15 cases 45 cores, replaced by FDA902b-2; ihc Anti-Actin confirmed US Biomax 858 |
FDA902-2 |
FDA Standard Frozen Tissue Array, for therapeutic and diagnostic antibody validation for FDA approval, 15 cases 45 cores, replaced by FDA902b-2; ihc Anti-Actin confirmed |
US Biomax |
|
858€ |
|
Pub |
FDA902 FDA Standard Frozen Tissue Array (2 slide set), for therapeutic and diagnostic monoclonal antibody validation recommanded by FDA, 90 tissue cores of 30 organs, 3 individual donors per organ US Biomax 199 |
FDA902 |
FDA Standard Frozen Tissue Array (2 slide set), for therapeutic and diagnostic monoclonal antibody validation recommanded by FDA, 90 tissue cores of 30 organs, 3 individual donors per organ |
US Biomax |
|
199€ |
|
Pub |
FRA901a-1 Normal rat multiple organ frozen tissue array, for therapeutic and diagnostic antibody validation for FDA approval, 45 cases 45 cores, slide 2 of 2 tissue arrays, replacing FRA901-1; ihc Anti-Actin c US Biomax 626 |
FRA901a-1 |
Normal rat multiple organ frozen tissue array, for therapeutic and diagnostic antibody validation for FDA approval, 45 cases 45 cores, slide 2 of 2 tissue arrays, replacing FRA901-1; ihc Anti-Actin c |
US Biomax |
|
626€ |
|
Pub |
FRA901a Normal rat multiple organ frozen tissue array, for therapeutic and diagnostic antibody validation, 45 cases 45 cores, 2 slides set, replacing FRA901; ihc Anti-Actin confirmed US Biomax 858 |
FRA901a |
Normal rat multiple organ frozen tissue array, for therapeutic and diagnostic antibody validation, 45 cases 45 cores, 2 slides set, replacing FRA901; ihc Anti-Actin confirmed |
US Biomax |
|
858€ |
|
Pub |
FRA901a-2 Normal rat multiple organ frozen tissue array, for therapeutic and diagnostic antibody validation for FDA approval, 45 cases 45 cores, slide 2 of 2 tissue arrays, replacing FRA901-2; ihc Anti-Actin c US Biomax 626 |
FRA901a-2 |
Normal rat multiple organ frozen tissue array, for therapeutic and diagnostic antibody validation for FDA approval, 45 cases 45 cores, slide 2 of 2 tissue arrays, replacing FRA901-2; ihc Anti-Actin c |
US Biomax |
|
626€ |
|
Pub |
FMO901-2 Normal mouse multiple organ frozen tissue array, for therapeutic and diagnostic antibody, 15 organs 45 cores, slide 2 of 2 tissue arrays; ihc Anti-Actin confirmed US Biomax 626 |
FMO901-2 |
Normal mouse multiple organ frozen tissue array, for therapeutic and diagnostic antibody, 15 organs 45 cores, slide 2 of 2 tissue arrays; ihc Anti-Actin confirmed |
US Biomax |
|
626€ |
|
Pub |
FRB901 FDA standard normal rabbit multiple organ frozen tissue array, slide one, 15 organs 45 cores US Biomax 331 |
FRB901 |
FDA standard normal rabbit multiple organ frozen tissue array, slide one, 15 organs 45 cores |
US Biomax |
|
331€ |
|
Pub |
FDA808a-2 Multiple organ tumor tissue array with adjacent normal human organs, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing FDA808-2; ihc Anti-Actin confirmed US Biomax 267 |
FDA808a-2 |
Multiple organ tumor tissue array with adjacent normal human organs, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing FDA808-2; ihc Anti-Actin confirmed |
US Biomax |
|
267€ |
|
Pub |
FFE301 Human normal fetal frozen tissue array, total of 15 major organs from one case, 15 organs 30 cores, replaced by FFE302 US Biomax 199 |
FFE301 |
Human normal fetal frozen tissue array, total of 15 major organs from one case, 15 organs 30 cores, replaced by FFE302 |
US Biomax |
|
199€ |
|
Pub |
FDA807-2 Multiple organ tumor tissue array with adjacent normal human organs, including TNM and pathology grade, 72 cases 72 cores, replacing FDA806 2 US Biomax 336 |
FDA807-2 |
Multiple organ tumor tissue array with adjacent normal human organs, including TNM and pathology grade, 72 cases 72 cores, replacing FDA806 2 |
US Biomax |
|
336€ |
|
Pub |
FMO901 FDA standard normal mouse multiple organ frozen tissue array, slide one, 15 organs 45 cores US Biomax 293 |
FMO901 |
FDA standard normal mouse multiple organ frozen tissue array, slide one, 15 organs 45 cores |
US Biomax |
|
293€ |
|
Pub |
FRA781 FDA standard normal rat multiple organ frozen tissue array, two slides, 26 cases 78 cores US Biomax 331 |
FRA781 |
FDA standard normal rat multiple organ frozen tissue array, two slides, 26 cases 78 cores |
US Biomax |
|
331€ |
|
Pub |
FMO721 FDA standard normal mouse multiple organ frozen tissue array, two slides, 24 cases 72 cores US Biomax 293 |
FMO721 |
FDA standard normal mouse multiple organ frozen tissue array, two slides, 24 cases 72 cores |
US Biomax |
|
293€ |
|
Pub |
FRA901-1 FDA standard normal rat multiple organ frozen tissue array, slide one, 15 cases 45 cores, replaced by FRA901a-1; ihc Anti-Actin confirmed US Biomax 626 |
FRA901-1 |
FDA standard normal rat multiple organ frozen tissue array, slide one, 15 cases 45 cores, replaced by FRA901a-1; ihc Anti-Actin confirmed |
US Biomax |
|
626€ |
|
Pub |
FDA808-2 Multiple organ tumor tissue array with adjacent normal human organs, including TNM and pathology grade, 72 cases 72 cores, replacing FDA805 2 US Biomax 277 |
FDA808-2 |
Multiple organ tumor tissue array with adjacent normal human organs, including TNM and pathology grade, 72 cases 72 cores, replacing FDA805 2 |
US Biomax |
|
277€ |
|
Pub |
FDA801 FDA normal and tumor organ tissue array of human (2 slide set), replaced by FDA802, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies. US Biomax 278 |
FDA801 |
FDA normal and tumor organ tissue array of human (2 slide set), replaced by FDA802, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies. |
US Biomax |
|
278€ |
|
Pub |
FFE302 Multiple organ normal frozen tissue array, 15 cases 30 cores, replacing FFE301 US Biomax 199 |
FFE302 |
Multiple organ normal frozen tissue array, 15 cases 30 cores, replacing FFE301 |
US Biomax |
|
199€ |
|
Pub |
FMC402a Multiple organ cancer frozen tissue array, with normal tissue, including pathology grade, 40 cases 40 cores, replaced by FMC402b; ihc Anti-Actin confirmed US Biomax 626 |
FMC402a |
Multiple organ cancer frozen tissue array, with normal tissue, including pathology grade, 40 cases 40 cores, replaced by FMC402b; ihc Anti-Actin confirmed |
US Biomax |
|
626€ |
|
Pub |
FDA808 FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA807, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies; ihc Anti-Actin confirmed US Biomax 296 |
FDA808 |
FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA807, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
FMC409 Multiple organ cancer frozen tissue array, 20 cases 40 cores replacing FMC401 US Biomax 281 |
FMC409 |
Multiple organ cancer frozen tissue array, 20 cases 40 cores replacing FMC401 |
US Biomax |
|
281€ |
|
Pub |
FCO401 Colorectal organ carcinoma frozen tissue array, including TNM, clinical stage, 40 cases 40 cores, replaced by FCO401a US Biomax 293 |
FCO401 |
Colorectal organ carcinoma frozen tissue array, including TNM, clinical stage, 40 cases 40 cores, replaced by FCO401a |
US Biomax |
|
293€ |
|
Pub |
FRA781-2 FDA standard normal rat multiple organ frozen tissue array, slide two, 26 cases 78 cores; ihc Anti-Actin confirmed US Biomax 626 |
FRA781-2 |
FDA standard normal rat multiple organ frozen tissue array, slide two, 26 cases 78 cores; ihc Anti-Actin confirmed |
US Biomax |
|
626€ |
|
Pub |
FDA999 Multiple organ normal tissue array, 47 cases 99 cores, replacing FDA998 US Biomax 314 |
FDA999 |
Multiple organ normal tissue array, 47 cases 99 cores, replacing FDA998 |
US Biomax |
|
314€ |
|
Pub |
FDA805 FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA804, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies US Biomax 314 |
FDA805 |
FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA804, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies |
US Biomax |
|
314€ |
|
Pub |
FDA993 FDA normal human organ tissue array, 67cases 100 cores, replaced by FDA995 US Biomax 278 |
FDA993 |
FDA normal human organ tissue array, 67cases 100 cores, replaced by FDA995 |
US Biomax |
|
278€ |
|
Pub |
FDA800 Multiple organ tumor tissue array, 72 cases of variety of cancers 72 cores, replacing FDA802 2 or FDA803 2 US Biomax 266 |
FDA800 |
Multiple organ tumor tissue array, 72 cases of variety of cancers 72 cores, replacing FDA802 2 or FDA803 2 |
US Biomax |
|
266€ |
|
Pub |
FBN407a Multiple organ normal frozen tissue array, 20 cases 40 cores, replaing FBN407; ihc Anti-Actin confirmed US Biomax 626 |
FBN407a |
Multiple organ normal frozen tissue array, 20 cases 40 cores, replaing FBN407; ihc Anti-Actin confirmed |
US Biomax |
|
626€ |
|
Pub |
FRA781-1 FDA standard normal rat multiple organ frozen tissue array, slide one, 26 cases 78 cores; ihc Anti-Actin confirmed US Biomax 626 |
FRA781-1 |
FDA standard normal rat multiple organ frozen tissue array, slide one, 26 cases 78 cores; ihc Anti-Actin confirmed |
US Biomax |
|
626€ |
|
Pub |
FDA998 FDA normal organ tissue array of human, 47 cases 99 cores, replaced by FDA999 US Biomax 314 |
FDA998 |
FDA normal organ tissue array of human, 47 cases 99 cores, replaced by FDA999 |
US Biomax |
|
314€ |
|
Pub |
FDA804 FDA normal and tumor organ tissue array of human (2 slide set), replaced by FDA805, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies US Biomax 278 |
FDA804 |
FDA normal and tumor organ tissue array of human (2 slide set), replaced by FDA805, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies |
US Biomax |
|
278€ |
|
Pub |
FMC405a Multiple organ cancer frozen tissue array, including pathology grade, 40 cases 40 cores, replacing FMC405; ihc Anti-Actin confirmed US Biomax 626 |
FMC405a |
Multiple organ cancer frozen tissue array, including pathology grade, 40 cases 40 cores, replacing FMC405; ihc Anti-Actin confirmed |
US Biomax |
|
626€ |
|
Pub |
FDA808a-1 Multiple organ normal tissue array, 72 cases 72 cores, replacing FDA808-1; ihc Anti-Actin confirmed US Biomax 267 |
FDA808a-1 |
Multiple organ normal tissue array, 72 cases 72 cores, replacing FDA808-1; ihc Anti-Actin confirmed |
US Biomax |
|
267€ |
|
Pub |
FBN401 Normal human multiple organ frozen tissue array (20 organs in duplicate), 20 cases 40 cores; ihc Anti-Actin confirmed US Biomax 278 |
FBN401 |
Normal human multiple organ frozen tissue array (20 organs in duplicate), 20 cases 40 cores; ihc Anti-Actin confirmed |
US Biomax |
|
278€ |
|
Pub |
FRA901-2 Normal rat multiple organ (recommended by FDA) frozen tissue array, slide two, 15 cases 45 cores, replaced by FRA901a-2; ihc Anti-Actin confirmed US Biomax 626 |
FRA901-2 |
Normal rat multiple organ (recommended by FDA) frozen tissue array, slide two, 15 cases 45 cores, replaced by FRA901a-2; ihc Anti-Actin confirmed |
US Biomax |
|
626€ |
|
Pub |
FMC282a Multiple organ cancer frozen tissue array, including pathology grade, 28 cases 28 cores, replacing FMC282; ihc Anti-Actin confirmed US Biomax 394 |
FMC282a |
Multiple organ cancer frozen tissue array, including pathology grade, 28 cases 28 cores, replacing FMC282; ihc Anti-Actin confirmed |
US Biomax |
|
394€ |
|
Pub |
FDA807 FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA806, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies; ihc Anti-Actin confirmed US Biomax 296 |
FDA807 |
FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA806, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
FMC407b Multiple organ cancer frozen tissue array, including TNM information, 40 cases 40 cores, replacing FMC407; ihc Anti-Actin confirmed US Biomax 626 |
FMC407b |
Multiple organ cancer frozen tissue array, including TNM information, 40 cases 40 cores, replacing FMC407; ihc Anti-Actin confirmed |
US Biomax |
|
626€ |
|
Pub |
FBN407 Multiple organ normal frozen tissue array, 20 cases 40 cores, replacing FBN404 US Biomax 281 |
FBN407 |
Multiple organ normal frozen tissue array, 20 cases 40 cores, replacing FBN404 |
US Biomax |
|
281€ |
|
Pub |
FDA997 FDA normal organ tissue array of human, 47 cases 99 cores, for FDA guidelines to test tissue specificity of antibodies, replaced by FDA998 US Biomax 314 |
FDA997 |
FDA normal organ tissue array of human, 47 cases 99 cores, for FDA guidelines to test tissue specificity of antibodies, replaced by FDA998 |
US Biomax |
|
314€ |
|
Pub |
FDA803 FDA normal and tumor organ tissue array of human (2 slide set), replaced by FDA804, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies. US Biomax 278 |
FDA803 |
FDA normal and tumor organ tissue array of human (2 slide set), replaced by FDA804, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies. |
US Biomax |
|
278€ |
|
Pub |
FDA808a FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA808, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies; ihc Anti-Actin confirmed US Biomax 296 |
FDA808a |
FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA808, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
FDA806 FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA805, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies US Biomax 380 |
FDA806 |
FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA805, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies |
US Biomax |
|
380€ |
|
Pub |
FBN406a Multiple organ normal frozen tissue array, 20 organs 40 cores; ihc Anti-Actin confirmed US Biomax 394 |
FBN406a |
Multiple organ normal frozen tissue array, 20 organs 40 cores; ihc Anti-Actin confirmed |
US Biomax |
|
394€ |
|
Pub |
FDA995 FDA normal human organ tissue array, 99 cores 33 sites 75 cases, replaced by FDA997 US Biomax 278 |
FDA995 |
FDA normal human organ tissue array, 99 cores 33 sites 75 cases, replaced by FDA997 |
US Biomax |
|
278€ |
|
Pub |
FDA802 FDA normal and tumor organ tissue array of human (2 slide set), replaced by FDA803, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies. US Biomax 278 |
FDA802 |
FDA normal and tumor organ tissue array of human (2 slide set), replaced by FDA803, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies. |
US Biomax |
|
278€ |
|
Pub |
FFE302a Multiple organ normal frozen tissue array, 15 organs 30 cores; ihc Anti-Actin confirmed US Biomax 394 |
FFE302a |
Multiple organ normal frozen tissue array, 15 organs 30 cores; ihc Anti-Actin confirmed |
US Biomax |
|
394€ |
|
Pub |
FMC402b Multiple organ cancer frozen tissue array, with normal tissue, including pathology grade, 40 cases 40 cores, replacing FMC402a; ihc Anti-Actin confirmed US Biomax 626 |
FMC402b |
Multiple organ cancer frozen tissue array, with normal tissue, including pathology grade, 40 cases 40 cores, replacing FMC402a; ihc Anti-Actin confirmed |
US Biomax |
|
626€ |
|
Pub |
FMC409a Frozen multiple organ cancer tissue array, 20 cases 40 cores, replacing FMC409; ihc Anti-Actin confirmed US Biomax 626 |
FMC409a |
Frozen multiple organ cancer tissue array, 20 cases 40 cores, replacing FMC409; ihc Anti-Actin confirmed |
US Biomax |
|
626€ |
|
Pub |
FDA999a Multiple organ normal tissue array, 47 cases 99 cores, replacing FDA999; ihc Anti-Actin confirmed US Biomax 296 |
FDA999a |
Multiple organ normal tissue array, 47 cases 99 cores, replacing FDA999; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
FDA805-2 Multiple organ cancer and 6 types of normal organ tissue array, including TNM and pathology grade, 72 cases 72 cores, replaced by FDA808 2 US Biomax 278 |
FDA805-2 |
Multiple organ cancer and 6 types of normal organ tissue array, including TNM and pathology grade, 72 cases 72 cores, replaced by FDA808 2 |
US Biomax |
|
278€ |
|
Pub |
FBN406 Multiple organ normal frozen tissue array, 20 cases 40 cores, replacing FBN404 US Biomax 167 |
FBN406 |
Multiple organ normal frozen tissue array, 20 cases 40 cores, replacing FBN404 |
US Biomax |
|
167€ |
|
Pub |
FDA994 FDA normal human organ tissue array, 99 cores 33 sites 75 cases, replacing FDA993, replaced by FDA995 US Biomax 314 |
FDA994 |
FDA normal human organ tissue array, 99 cores 33 sites 75 cases, replacing FDA993, replaced by FDA995 |
US Biomax |
|
314€ |
|
Pub |
MC964 Multiple organ tumor tissue array, including TNM, clinical stage and pathology grade, for testing tumor tissue specificity of therapeutic antibodies, 96 cases 96 cores, replacing MC961 US Biomax 266 |
MC964 |
Multiple organ tumor tissue array, including TNM, clinical stage and pathology grade, for testing tumor tissue specificity of therapeutic antibodies, 96 cases 96 cores, replacing MC961 |
US Biomax |
|
266€ |
|
Pub |
CyFDA1 FDA multiple organ normal tissue array of cynomolgus monkey, 34 organs 99 cores, replacing CyFDA; ihc Anti-Actin confirmed US Biomax 296 |
CyFDA1 |
FDA multiple organ normal tissue array of cynomolgus monkey, 34 organs 99 cores, replacing CyFDA; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
FBN404 Multiple organ normal frozen tissue array, 20 cases 40 cores US Biomax 167 |
FBN404 |
Multiple organ normal frozen tissue array, 20 cases 40 cores |
US Biomax |
|
167€ |
|
Pub |
FMC402 Multiple organ cancer frozen tissue array, with normal tissue 40 cases 40 cores US Biomax 91 |
FMC402 |
Multiple organ cancer frozen tissue array, with normal tissue 40 cases 40 cores |
US Biomax |
|
91€ |
|
Pub |
FMC408 Multiple organ cancer frozen tissue array, including TNM and clinical stage, 40 cases 40 cores US Biomax 167 |
FMC408 |
Multiple organ cancer frozen tissue array, including TNM and clinical stage, 40 cases 40 cores |
US Biomax |
|
167€ |
|
Pub |
FRB281m Normal male rabbit multiple organ frozen tissue array, 28 cases 28 cores US Biomax 293 |
FRB281m |
Normal male rabbit multiple organ frozen tissue array, 28 cases 28 cores |
US Biomax |
|
293€ |
|
Pub |
FDG281m Normal male dog multiple organ frozen tissue array, 28 cases 28 cores US Biomax 199 |
FDG281m |
Normal male dog multiple organ frozen tissue array, 28 cases 28 cores |
US Biomax |
|
199€ |
|
Pub |
FRB281f Normal female rabbit multiple organ frozen tissue array, 28 cases 28 cores US Biomax 293 |
FRB281f |
Normal female rabbit multiple organ frozen tissue array, 28 cases 28 cores |
US Biomax |
|
293€ |
|
Pub |
FMC405 Multiple organ carcinoma frozen tissue array, including TNM and clinical stage, 40 cases 40 cores US Biomax 167 |
FMC405 |
Multiple organ carcinoma frozen tissue array, including TNM and clinical stage, 40 cases 40 cores |
US Biomax |
|
167€ |
|
Pub |
FDG281f Normal dog multiple organ frozen tissue array, 28 cases 28 cores US Biomax 199 |
FDG281f |
Normal dog multiple organ frozen tissue array, 28 cases 28 cores |
US Biomax |
|
199€ |
|
Pub |
MC961 Multiple organ cancer tissue array for testing tumor tissue specificity of therapeutic antibodies, 96 cases 96 cores, replaced by MC964 US Biomax 231 |
MC961 |
Multiple organ cancer tissue array for testing tumor tissue specificity of therapeutic antibodies, 96 cases 96 cores, replaced by MC964 |
US Biomax |
|
231€ |
|
Pub |
FMC407 Multiple organ cancer frozen tissue array, including TNM and clinical stage, 40 cases 40 cores US Biomax 331 |
FMC407 |
Multiple organ cancer frozen tissue array, including TNM and clinical stage, 40 cases 40 cores |
US Biomax |
|
331€ |
|
Pub |
FCO401a Frozen colorectal adenocarcinoma tissue array, including TNM and clinical stage, 40 cases 40 cores, replacing FCO401 US Biomax 781 |
FCO401a |
Frozen colorectal adenocarcinoma tissue array, including TNM and clinical stage, 40 cases 40 cores, replacing FCO401 |
US Biomax |
|
781€ |
|
Pub |
FRA901 Normal rat multiple organ (recommended by FDA) frozen tissue array, slide one, 15 cases 45 cores US Biomax 331 |
FRA901 |
Normal rat multiple organ (recommended by FDA) frozen tissue array, slide one, 15 cases 45 cores |
US Biomax |
|
331€ |
|
Pub |
FMC406c Frozen multiple human organ cancer tissue array, including TNM and clinical stage, 40 cases 40 cores; ihc Anti-Actin confirmed US Biomax 626 |
FMC406c |
Frozen multiple human organ cancer tissue array, including TNM and clinical stage, 40 cases 40 cores; ihc Anti-Actin confirmed |
US Biomax |
|
626€ |
|
Pub |
MC641 Multiple organ cancer and adjacent normal tissue array, including TNM and pathology grade, 59 cases 64 cores, replacing BC00115 US Biomax 0 |
MC641 |
Multiple organ cancer and adjacent normal tissue array, including TNM and pathology grade, 59 cases 64 cores, replacing BC00115 |
US Biomax |
|
0€ |
|
Pub |
BCN963 Multiple organ cancer and adjacent normal tissue array, including TNM and pathology grade, 78 cases 96 cores, replacing BCN961 US Biomax 266 |
BCN963 |
Multiple organ cancer and adjacent normal tissue array, including TNM and pathology grade, 78 cases 96 cores, replacing BCN961 |
US Biomax |
|
266€ |
|
Pub |
BRF401 Breast cancer frozen tissue array, with normal tissue, 40 cases 40 cores, Her-2 and ER PR IHC are supplied when purchase; ihc Anti-Actin confirmed US Biomax 742 |
BRF401 |
Breast cancer frozen tissue array, with normal tissue, 40 cases 40 cores, Her-2 and ER PR IHC are supplied when purchase; ihc Anti-Actin confirmed |
US Biomax |
|
742€ |
|
Pub |
BN1002a Multiple organ normal tissue array, 100 cases 100 cores, replacing BN1002; ihc Anti-Actin confirmed US Biomax 296 |
BN1002a |
Multiple organ normal tissue array, 100 cases 100 cores, replacing BN1002; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
FMC406 Digestive system carcinoma frozen tissue array, including TNM and clinical stage information, 40 cases 40 cores US Biomax 167 |
FMC406 |
Digestive system carcinoma frozen tissue array, including TNM and clinical stage information, 40 cases 40 cores |
US Biomax |
|
167€ |
|
Pub |
MC5002 High density multiple organ tumor tissue array, with adjacent normal tissue, information of TNM, stage and grade, 500 cases 500 cores, replacing MC5001 US Biomax 634 |
MC5002 |
High density multiple organ tumor tissue array, with adjacent normal tissue, information of TNM, stage and grade, 500 cases 500 cores, replacing MC5001 |
US Biomax |
|
634€ |
|
Pub |
BC00119 Multiple organ diseased tissue array, 32 cases 32 cores, replaced by MC483 US Biomax 160 |
BC00119 |
Multiple organ diseased tissue array, 32 cases 32 cores, replaced by MC483 |
US Biomax |
|
160€ |
|
Pub |
BN116 Multiple organ normal tissue array, 48 cases 48 cores, replaced by BN129 US Biomax 189 |
BN116 |
Multiple organ normal tissue array, 48 cases 48 cores, replaced by BN129 |
US Biomax |
|
189€ |
|
Pub |
BC01071a Multiple organ cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing BC01071; ihc Anti-Actin confirmed US Biomax 185 |
BC01071a |
Multiple organ cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing BC01071; ihc Anti-Actin confirmed |
US Biomax |
|
185€ |
|
Pub |
LC2081 Multiple lung carcinoma (Non small cell lung carcinoma, NSCLC) and normal tissue form necroscopy tissue array, 70 cases 208 cores, with stage and grade information US Biomax 456 |
LC2081 |
Multiple lung carcinoma (Non small cell lung carcinoma, NSCLC) and normal tissue form necroscopy tissue array, 70 cases 208 cores, with stage and grade information |
US Biomax |
|
456€ |
|
Pub |
MC631 Multiple organ, diseased tissue array (63 cases 63 cores, 20 types of cancer and disease), replacing BC00014 US Biomax 160 |
MC631 |
Multiple organ, diseased tissue array (63 cases 63 cores, 20 types of cancer and disease), replacing BC00014 |
US Biomax |
|
160€ |
|
Pub |
LN802 Multiple organ lymph tissue array, 80 cases 80 cores, replacing LN801 US Biomax 231 |
LN802 |
Multiple organ lymph tissue array, 80 cases 80 cores, replacing LN801 |
US Biomax |
|
231€ |
|
Pub |
BC00014 Multiple organ diseased tissue array, 63 cases 63 cores, replaced by MC631 US Biomax 160 |
BC00014 |
Multiple organ diseased tissue array, 63 cases 63 cores, replaced by MC631 |
US Biomax |
|
160€ |
|
Pub |
BN1002 Multiple organ (20) normal tissue array, 100 cases 100 cores, replacing BN1001 US Biomax 266 |
BN1002 |
Multiple organ (20) normal tissue array, 100 cases 100 cores, replacing BN1001 |
US Biomax |
|
266€ |
|
Pub |
MC542 Multiple organ diseased tissue array, including TNM and pathology grade, 54 cases 54 cores, replacing MC541 US Biomax 160 |
MC542 |
Multiple organ diseased tissue array, including TNM and pathology grade, 54 cases 54 cores, replacing MC541 |
US Biomax |
|
160€ |
|
Pub |
MC244 Multiple organ cancer and normal adjacent tissue array, replacing MC241, 12 cases 24 cores US Biomax 88 |
MC244 |
Multiple organ cancer and normal adjacent tissue array, replacing MC241, 12 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
BN00119 Multiple organ normal tissue array, 40 cases 40 cores, replacing BN00112 US Biomax 266 |
BN00119 |
Multiple organ normal tissue array, 40 cases 40 cores, replacing BN00112 |
US Biomax |
|
266€ |
|
Pub |
BC001111 Multiple organ normal and diseased tissue array, 58 cases 60 cores, replaced by MCN601 US Biomax 231 |
BC001111 |
Multiple organ normal and diseased tissue array, 58 cases 60 cores, replaced by MCN601 |
US Biomax |
|
231€ |
|
Pub |
MC5001 High density (495 cases 500 cores) tissue array of multiple organ cancer and normal, with stage and grade information, replaced by MC5002 US Biomax 634 |
MC5001 |
High density (495 cases 500 cores) tissue array of multiple organ cancer and normal, with stage and grade information, replaced by MC5002 |
US Biomax |
|
634€ |
|
Pub |
MCN602 Multiple organ tumor and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 58 cases 60 cores, replacing MCN601 US Biomax 231 |
MCN602 |
Multiple organ tumor and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 58 cases 60 cores, replacing MCN601 |
US Biomax |
|
231€ |
|
Pub |
BCN961 Multiple organ cancer tissue array with adjacent cancer tissue control tissue array, 57 cases 96 cores, replaced by BCN963 US Biomax 231 |
BCN961 |
Multiple organ cancer tissue array with adjacent cancer tissue control tissue array, 57 cases 96 cores, replaced by BCN963 |
US Biomax |
|
231€ |
|
Pub |
MC803a Multiple organ tumor tissue array with adjacent normal tissue, including TNM and clinical stage, 40 cases 80 cores, replacing MC803; ihc Anti-Actin confirmed US Biomax 320 |
MC803a |
Multiple organ tumor tissue array with adjacent normal tissue, including TNM and clinical stage, 40 cases 80 cores, replacing MC803; ihc Anti-Actin confirmed |
US Biomax |
|
320€ |
|
Pub |
MC541 Multiple organ, diseased tissue array (54 cases 54 cores, 18 types of cancers), replaced by MC542 US Biomax 160 |
MC541 |
Multiple organ, diseased tissue array (54 cases 54 cores, 18 types of cancers), replaced by MC542 |
US Biomax |
|
160€ |
|
Pub |
BN129 Multiple organ adjacent normal tissue array, 48 cases 48 cores, replacing BN116 US Biomax 160 |
BN129 |
Multiple organ adjacent normal tissue array, 48 cases 48 cores, replacing BN116 |
US Biomax |
|
160€ |
|
Pub |
BN961 Normal human tissue panel (24 organs) with two serial tissue array sections in parallel, 24 cases 102 cores, replacing BN861 US Biomax 266 |
BN961 |
Normal human tissue panel (24 organs) with two serial tissue array sections in parallel, 24 cases 102 cores, replacing BN861 |
US Biomax |
|
266€ |
|
Pub |
BN00112 Multiple organ normal tissue array, 40cases 40 cores, replaced by BN00119 US Biomax 160 |
BN00112 |
Multiple organ normal tissue array, 40cases 40 cores, replaced by BN00119 |
US Biomax |
|
160€ |
|
Pub |
BC00111 Multiple organ normal and diseased tissue array (replaced by MCN601), 54 cases 60 cores US Biomax 231 |
BC00111 |
Multiple organ normal and diseased tissue array (replaced by MCN601), 54 cases 60 cores |
US Biomax |
|
231€ |
|
Pub |
BC00115 Multiple organ normal and diseased tissue array, 44 cases 64 cores, replaced by MC802 US Biomax 231 |
BC00115 |
Multiple organ normal and diseased tissue array, 44 cases 64 cores, replaced by MC802 |
US Biomax |
|
231€ |
|
Pub |
MCN601 Multiple organ tumor and normal tissue array, 58 cases 60 cores, replaced by MCN602 US Biomax 231 |
MCN601 |
Multiple organ tumor and normal tissue array, 58 cases 60 cores, replaced by MCN602 |
US Biomax |
|
231€ |
|
Pub |
BR01015 Multiple organ, normal tissue array, 8 normal tissues, 160 cases 160 cores, replacing BR01011 US Biomax 278 |
BR01015 |
Multiple organ, normal tissue array, 8 normal tissues, 160 cases 160 cores, replacing BR01011 |
US Biomax |
|
278€ |
|
Pub |
FMC281 Multiple tumor and corresponding normal frozen tissue (14 types) array, 14 cases 28 cores, previously named FMC401; ihc Anti-Actin confirmed US Biomax 394 |
FMC281 |
Multiple tumor and corresponding normal frozen tissue (14 types) array, 14 cases 28 cores, previously named FMC401; ihc Anti-Actin confirmed |
US Biomax |
|
394€ |
|
Pub |
BC00012 Multiple organ diseased tissue array, 30 cases 60 cores, replaced by MC801 US Biomax 160 |
BC00012 |
Multiple organ diseased tissue array, 30 cases 60 cores, replaced by MC801 |
US Biomax |
|
160€ |
|
Pub |
RAT901 Rat multiple organs, normal tissue array, 22 cases 90 cores, replacing BR01013 US Biomax 231 |
RAT901 |
Rat multiple organs, normal tissue array, 22 cases 90 cores, replacing BR01013 |
US Biomax |
|
231€ |
|
Pub |
FMS152 Liver of multiple species frozen tissue array, 14 cases 15 cores US Biomax 293 |
FMS152 |
Liver of multiple species frozen tissue array, 14 cases 15 cores |
US Biomax |
|
293€ |
|
Pub |
BN126 Multiple organ normal tissue array, replacing BN113, 45 cases 45 cores US Biomax 231 |
BN126 |
Multiple organ normal tissue array, replacing BN113, 45 cases 45 cores |
US Biomax |
|
231€ |
|
Pub |
BCN963a Multiple organ tumor and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 81 cases 96 cores, replacing BCN963; ihc Anti-Actin confirmed US Biomax 258 |
BCN963a |
Multiple organ tumor and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 81 cases 96 cores, replacing BCN963; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
BRF404 Breast invasive ductal carcinoma forzen tissue array, 20 cases 40 cores US Biomax 167 |
BRF404 |
Breast invasive ductal carcinoma forzen tissue array, 20 cases 40 cores |
US Biomax |
|
167€ |
|
Pub |
BN501 Normal human top 10 organ tissue array, 50 cases 50 cores, replacing BN00012 and BN00013 US Biomax 160 |
BN501 |
Normal human top 10 organ tissue array, 50 cases 50 cores, replacing BN00012 and BN00013 |
US Biomax |
|
160€ |
|
Pub |
PRF281 Prostate cancer frozen tissue array, with grade and Gleason scores and normal prostate tissue control, 28 cases 28 cores; ihc H&E and Anti-Actin confirmed US Biomax 742.35 |
PRF281 |
Prostate cancer frozen tissue array, with grade and Gleason scores and normal prostate tissue control, 28 cases 28 cores; ihc H&E and Anti-Actin confirmed |
US Biomax |
|
742.35€ |
|
Pub |
BN113 Multiple organ normal tissue array, replaced by BN126, 45 cases 45 cores US Biomax 189 |
BN113 |
Multiple organ normal tissue array, replaced by BN126, 45 cases 45 cores |
US Biomax |
|
189€ |
|
Pub |
BN243a Multiple organ normal tissue array, 12 cases 24 cores, replacing BN243; ihc Anti-Actin confirmed US Biomax 105 |
BN243a |
Multiple organ normal tissue array, 12 cases 24 cores, replacing BN243; ihc Anti-Actin confirmed |
US Biomax |
|
105€ |
|
Pub |
MC246 Multiple organ tumor with matched adjacent normal tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing MC244; ihc Anti-Actin confirmed US Biomax 90 |
MC246 |
Multiple organ tumor with matched adjacent normal tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing MC244; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
FMS151 Brains of multiple species frozen tissue array, 14 cases 15 cores US Biomax 293 |
FMS151 |
Brains of multiple species frozen tissue array, 14 cases 15 cores |
US Biomax |
|
293€ |
|
Pub |
MC5003 High density multiple organ tumor and normal tissue array, with TNM and pathology grade, 500 cases 500 cores, replacing MC5002 US Biomax 634 |
MC5003 |
High density multiple organ tumor and normal tissue array, with TNM and pathology grade, 500 cases 500 cores, replacing MC5002 |
US Biomax |
|
634€ |
|
Pub |
KD1002 Kidney cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores US Biomax 231 |
KD1002 |
Kidney cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores |
US Biomax |
|
231€ |
|
Pub |
BN117 Multiple organ normal tissue array, 45 cases 45 cores US Biomax 189 |
BN117 |
Multiple organ normal tissue array, 45 cases 45 cores |
US Biomax |
|
189€ |
|
Pub |
T192 Prostate cancer test tissue array, with normal control tissue, including TNM, clinical stage, pathology grade, gleason grade and gleason score, 12 cases 24 cores, replaced by T195 US Biomax 88 |
T192 |
Prostate cancer test tissue array, with normal control tissue, including TNM, clinical stage, pathology grade, gleason grade and gleason score, 12 cases 24 cores, replaced by T195 |
US Biomax |
|
88€ |
|
Pub |
PR8011 Prostate disease spectrum tissue array, including TNM and pathology grade, 80 cases 80 cores, replacing PR805 US Biomax 314 |
PR8011 |
Prostate disease spectrum tissue array, including TNM and pathology grade, 80 cases 80 cores, replacing PR805 |
US Biomax |
|
314€ |
|
Pub |
LY121a Diffuse large B-cell lymphoma tissue array, 12 cases 12 cores, replacing LY121; ihc Anti-Actin confirmed US Biomax 185 |
LY121a |
Diffuse large B-cell lymphoma tissue array, 12 cases 12 cores, replacing LY121; ihc Anti-Actin confirmed |
US Biomax |
|
185€ |
|
Pub |
BS06041 Rectum adenocarcinoma (grade III) tissue array, 21 cases 63 cores, replaced by RE724 US Biomax 160 |
BS06041 |
Rectum adenocarcinoma (grade III) tissue array, 21 cases 63 cores, replaced by RE724 |
US Biomax |
|
160€ |
|
Pub |
IC00011 Tissue array of gastritis with intestinal metaplasia and gastric carcinoma, 80 cases 80 cores, replaced by IC00011b US Biomax 231 |
IC00011 |
Tissue array of gastritis with intestinal metaplasia and gastric carcinoma, 80 cases 80 cores, replaced by IC00011b |
US Biomax |
|
231€ |
|
Pub |
PA1003 Pancreas cancer tissue array for antibody screening, including TNM and pathology grade, 25 cases 100 cores US Biomax 314 |
PA1003 |
Pancreas cancer tissue array for antibody screening, including TNM and pathology grade, 25 cases 100 cores |
US Biomax |
|
314€ |
|
Pub |
MO541 Mouse multiple organ normal tissue array, 24 cases 54 cores; ihc Anti-Actin confirmed US Biomax 162 |
MO541 |
Mouse multiple organ normal tissue array, 24 cases 54 cores; ihc Anti-Actin confirmed |
US Biomax |
|
162€ |
|
Pub |
BR8012 Breast cancer and normal tissue array with stage and grade info, 40 cases 80 cores, replaced by BR8014 US Biomax 231 |
BR8012 |
Breast cancer and normal tissue array with stage and grade info, 40 cases 80 cores, replaced by BR8014 |
US Biomax |
|
231€ |
|
Pub |
CO1002b Colorectal carcinoma and matched adjacent normal tissue array with lymph node metastasis carcinoma, including TNM and pathology grade, 64 cases 100 cores, replacing CO1002 US Biomax 321 |
CO1002b |
Colorectal carcinoma and matched adjacent normal tissue array with lymph node metastasis carcinoma, including TNM and pathology grade, 64 cases 100 cores, replacing CO1002 |
US Biomax |
|
321€ |
|
Pub |
OV802 Multiple ovarian carcinoma and normal tissue array, with stage and TNM info, 78 cases 80 cores, replacing BC11011 US Biomax 231 |
OV802 |
Multiple ovarian carcinoma and normal tissue array, with stage and TNM info, 78 cases 80 cores, replacing BC11011 |
US Biomax |
|
231€ |
|
Pub |
LC721 Non small cell lung carcinoma (NSCLC) tissue array, 24 cases 72 cores, replacing BC04011 US Biomax 231 |
LC721 |
Non small cell lung carcinoma (NSCLC) tissue array, 24 cases 72 cores, replacing BC04011 |
US Biomax |
|
231€ |
|
Pub |
BR243c Breast cancer tissue array with matched adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replaced by BR243d; ihc Anti-Actin confirmed US Biomax 90 |
BR243c |
Breast cancer tissue array with matched adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replaced by BR243d; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
M37091733 4 Formylimidazole (4(5) Imidazolecarboxaldehyde) CAS Number [3034 50 2] Molekula 1 G 88 |
M37091733 |
4 Formylimidazole (4(5) Imidazolecarboxaldehyde) CAS Number [3034 50 2] |
Molekula |
1 G |
88€ |
|
Pub |
BC30011 Heart tissue array, 13 cases 34 cores, replaced by BC30013 US Biomax 231 |
BC30011 |
Heart tissue array, 13 cases 34 cores, replaced by BC30013 |
US Biomax |
|
231€ |
|
Pub |
T045 Lung cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replaced by T045b US Biomax 88 |
T045 |
Lung cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replaced by T045b |
US Biomax |
|
88€ |
|
Pub |
SO805 Neurilemmoma of peripheral nerve tissue array, 80 cases 80 cores US Biomax 231 |
SO805 |
Neurilemmoma of peripheral nerve tissue array, 80 cases 80 cores |
US Biomax |
|
231€ |
|
Pub |
T054a Colon cancer tissue array with normal colon tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T054; ihc Anti-Actin confirmed US Biomax 90 |
T054a |
Colon cancer tissue array with normal colon tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T054; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
RE723 Rectal adenocarcinoma (grade 2) tissue array, with stage, TNM and grade, 24 cases 72 cores, replacing BS06031 US Biomax 231 |
RE723 |
Rectal adenocarcinoma (grade 2) tissue array, with stage, TNM and grade, 24 cases 72 cores, replacing BS06031 |
US Biomax |
|
231€ |
|
Pub |
MC241 Multiple cancer (12 type) tissue array, 12 cases 24 cores, replaced by MC244 US Biomax 88 |
MC241 |
Multiple cancer (12 type) tissue array, 12 cases 24 cores, replaced by MC244 |
US Biomax |
|
88€ |
|
Pub |
BN484 Multiple organ normal tissue array, 24 cases 48 cores US Biomax 231 |
BN484 |
Multiple organ normal tissue array, 24 cases 48 cores |
US Biomax |
|
231€ |
|
Pub |
PR808 Prostate cancer and normal tissue array, with TNM, stage, Gleason's score and grade info, 40 cases 80 cores, replacing BC19012 US Biomax 266 |
PR808 |
Prostate cancer and normal tissue array, with TNM, stage, Gleason's score and grade info, 40 cases 80 cores, replacing BC19012 |
US Biomax |
|
266€ |
|
Pub |
OV2084 Ovarian cancer tissue array with normal adjacent ovary, TNM, clinical stage and pathology grade, 208 cases 208 cores, replaced by OV20814 US Biomax 456 |
OV2084 |
Ovarian cancer tissue array with normal adjacent ovary, TNM, clinical stage and pathology grade, 208 cases 208 cores, replaced by OV20814 |
US Biomax |
|
456€ |
|
Pub |
BS20011 Lymphoma tissue array, 30 cases 30 cores, replaced by NHL481 US Biomax 189 |
BS20011 |
Lymphoma tissue array, 30 cases 30 cores, replaced by NHL481 |
US Biomax |
|
189€ |
|
Pub |
BC11012a Ovary cancer tissue array, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing BC11012; ihc Anti-Actin confirmed US Biomax 185 |
BC11012a |
Ovary cancer tissue array, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing BC11012; ihc Anti-Actin confirmed |
US Biomax |
|
185€ |
|
Pub |
T004 Multiple organ cancer and normal tissue array, including TNM and pathology grade, 6 cases 24 cores US Biomax 88 |
T004 |
Multiple organ cancer and normal tissue array, including TNM and pathology grade, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
MT2081 Multiple organ metastatic cancer tissue array, 19 organ 104 cases 208 cores US Biomax 456 |
MT2081 |
Multiple organ metastatic cancer tissue array, 19 organ 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
BR803 Breast carcinoma (multi tissue combined panel) tissue array, 79 cases 80 cores, replacing BC08016 US Biomax 189 |
BR803 |
Breast carcinoma (multi tissue combined panel) tissue array, 79 cases 80 cores, replacing BC08016 |
US Biomax |
|
189€ |
|
Pub |
BN00011 Multiple organ normal tissue array, 48 cases 48 cores US Biomax 160 |
BN00011 |
Multiple organ normal tissue array, 48 cases 48 cores |
US Biomax |
|
160€ |
|
Pub |
BC00016 Multiple organ diseased tissues, 54 cases 54 cores, replaced by MC541 US Biomax 160 |
BC00016 |
Multiple organ diseased tissues, 54 cases 54 cores, replaced by MC541 |
US Biomax |
|
160€ |
|
Pub |
BR1007 Breast cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 266 |
BR1007 |
Breast cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores |
US Biomax |
|
266€ |
|
Pub |
T385 Malignant melanoma test tissue array, with normal skin tissue as control, including TNM and clinical stage, 6 cases 24 cores, replaced by T386 US Biomax 88 |
T385 |
Malignant melanoma test tissue array, with normal skin tissue as control, including TNM and clinical stage, 6 cases 24 cores, replaced by T386 |
US Biomax |
|
88€ |
|
Pub |
BC05115 Colon cancer, metastasize to lymph node and liver, and normal tissue array, including TNM, clinical stage and pathology grade, 68 cases 69 cores, replaced by CO702 US Biomax 231 |
BC05115 |
Colon cancer, metastasize to lymph node and liver, and normal tissue array, including TNM, clinical stage and pathology grade, 68 cases 69 cores, replaced by CO702 |
US Biomax |
|
231€ |
|
Pub |
ST801a Stomach cancer tissue array with matched adjacent normal stomach tissue, including TNM and clinical stage, 40 cases 80 cores, replacing ST801; ihc Anti-Actin confirmed US Biomax 267 |
ST801a |
Stomach cancer tissue array with matched adjacent normal stomach tissue, including TNM and clinical stage, 40 cases 80 cores, replacing ST801; ihc Anti-Actin confirmed |
US Biomax |
|
267€ |
|
Pub |
BS04011 Lung squamous carcinoma (combination of adjacent and normal) tissue array, 18 cases 54 cores, replaced by LC808 US Biomax 160 |
BS04011 |
Lung squamous carcinoma (combination of adjacent and normal) tissue array, 18 cases 54 cores, replaced by LC808 |
US Biomax |
|
160€ |
|
Pub |
LC1002 Lung adenocarcinoma (grade II III) tissue array with self matched adjacent normal tissue, and 4 non cancer normal lung tissue, 52 cases 100 cores, replaced by LC10013 US Biomax 231 |
LC1002 |
Lung adenocarcinoma (grade II III) tissue array with self matched adjacent normal tissue, and 4 non cancer normal lung tissue, 52 cases 100 cores, replaced by LC10013 |
US Biomax |
|
231€ |
|
Pub |
BC07013 Kidney carcinoma (multi tissue combined panel) tissue array, 23 cases 63 cores, replacing BC07011 US Biomax 160 |
BC07013 |
Kidney carcinoma (multi tissue combined panel) tissue array, 23 cases 63 cores, replacing BC07011 |
US Biomax |
|
160€ |
|
Pub |
MC483 Multiple types of cancer tissue array with normal control, replacing BC00119, 26 cases 48 cores, with stage and grade data US Biomax 160 |
MC483 |
Multiple types of cancer tissue array with normal control, replacing BC00119, 26 cases 48 cores, with stage and grade data |
US Biomax |
|
160€ |
|
Pub |
T231a Testis tumor tissue array with normal tissue as control, including TNM and clinical stage, 6 cases 24 cores, replacing T231; ihc Anti-Actin confirmed US Biomax 90 |
T231a |
Testis tumor tissue array with normal tissue as control, including TNM and clinical stage, 6 cases 24 cores, replacing T231; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
BC04011 Lung cancer tissue array, including pathology grade, 23 cases 63 cores, replaced by LC721; ihc Anti-Cytokeratin (CK) confirmed US Biomax 185 |
BC04011 |
Lung cancer tissue array, including pathology grade, 23 cases 63 cores, replaced by LC721; ihc Anti-Cytokeratin (CK) confirmed |
US Biomax |
|
185€ |
|
Pub |
ME481a Melanoma tissue array with normal skin tissues, including TNM and clinical stage, 48 cases 48 cores, replacing ME481; ihc Anti-Actin confirmed US Biomax 185 |
ME481a |
Melanoma tissue array with normal skin tissues, including TNM and clinical stage, 48 cases 48 cores, replacing ME481; ihc Anti-Actin confirmed |
US Biomax |
|
185€ |
|
Pub |
BR2085a High density (188 cases 208 cores), multiple types of breast cancer of infiltrating ductal, lobular carcinoma and normal breast tissue array, replaced by BR2085c. US Biomax 456 |
BR2085a |
High density (188 cases 208 cores), multiple types of breast cancer of infiltrating ductal, lobular carcinoma and normal breast tissue array, replaced by BR2085c. |
US Biomax |
|
456€ |
|
Pub |
BC19012 Prostate carcinoma (multi tissue combined panel) tissue array, 33 cases 63 cores, replaced by PR808 US Biomax 231 |
BC19012 |
Prostate carcinoma (multi tissue combined panel) tissue array, 33 cases 63 cores, replaced by PR808 |
US Biomax |
|
231€ |
|
Pub |
BN05011 Normal colon tissue (multi site) array, 23 cases 63 cores, replaced by BN05014 US Biomax 160 |
BN05011 |
Normal colon tissue (multi site) array, 23 cases 63 cores, replaced by BN05014 |
US Biomax |
|
160€ |
|
Pub |
BC001134 Multiple organs tumor and normal tissue array, including TNM, clinical stage and pathology grade, 150 cases 150 cores US Biomax 397 |
BC001134 |
Multiple organs tumor and normal tissue array, including TNM, clinical stage and pathology grade, 150 cases 150 cores |
US Biomax |
|
397€ |
|
Pub |
BR963a Breast disease spectrum tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores, replacing BR963; ihc Anti-Actin confirmed US Biomax 296 |
BR963a |
Breast disease spectrum tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores, replacing BR963; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
T174 Brain tumor test tissue array, with normal tissue, including TNM and pathology grade, 6 cases 24 cores, replacing T171 US Biomax 88 |
T174 |
Brain tumor test tissue array, with normal tissue, including TNM and pathology grade, 6 cases 24 cores, replacing T171 |
US Biomax |
|
88€ |
|
Pub |
OV1005 Ovarian disease spectrum (ovarian cancer progression) tissue array, including TNM, clinical stage and pathology grade, 100 cases 100 cores, replacing OV1001 US Biomax 266 |
OV1005 |
Ovarian disease spectrum (ovarian cancer progression) tissue array, including TNM, clinical stage and pathology grade, 100 cases 100 cores, replacing OV1001 |
US Biomax |
|
266€ |
|
Pub |
BS05031 Colon adenocarcinoma (grade II) tissue array, 21 cases 63 cores, replaced by CO724 US Biomax 160 |
BS05031 |
Colon adenocarcinoma (grade II) tissue array, 21 cases 63 cores, replaced by CO724 |
US Biomax |
|
160€ |
|
Pub |
BC08016 Breast carcinoma (multi tissue combined panel) tissue array, 63 cases 63 cores, replaced by BR803 US Biomax 160 |
BC08016 |
Breast carcinoma (multi tissue combined panel) tissue array, 63 cases 63 cores, replaced by BR803 |
US Biomax |
|
160€ |
|
Pub |
BR727 Breast cancer and normal tissue array, with TNM, stage and grade info, 24 cases 72 cores, replacing BS08011 US Biomax 231 |
BR727 |
Breast cancer and normal tissue array, with TNM, stage and grade info, 24 cases 72 cores, replacing BS08011 |
US Biomax |
|
231€ |
|
Pub |
BL802 Bladder cancer tissue array with normal tissue, 80 cases 80 cores, replacing BC12012 US Biomax 266 |
BL802 |
Bladder cancer tissue array with normal tissue, 80 cases 80 cores, replacing BC12012 |
US Biomax |
|
266€ |
|
Pub |
RhFDA1 FDA normal organ tissue array of rhesus monkey, 99 cases 99 cores US Biomax 278 |
RhFDA1 |
FDA normal organ tissue array of rhesus monkey, 99 cases 99 cores |
US Biomax |
|
278€ |
|
Pub |
MC601 Multi organ cancer tissue array, including TNM, clinical stage and pathology grade, 60 cases 60 cores US Biomax 231 |
MC601 |
Multi organ cancer tissue array, including TNM, clinical stage and pathology grade, 60 cases 60 cores |
US Biomax |
|
231€ |
|
Pub |
ST483a Stomach cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing ST483; ihc Anti-Actin confirmed US Biomax 185 |
ST483a |
Stomach cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing ST483; ihc Anti-Actin confirmed |
US Biomax |
|
185€ |
|
Pub |
BC21014 Skin malignant tumor tissue array, 78 cases 78 cores, replacing BC21011 US Biomax 231 |
BC21014 |
Skin malignant tumor tissue array, 78 cases 78 cores, replacing BC21011 |
US Biomax |
|
231€ |
|
Pub |
LC725 Normal lung tissue array, 24 cases 72 cores, replacing BN04011 US Biomax 278 |
LC725 |
Normal lung tissue array, 24 cases 72 cores, replacing BN04011 |
US Biomax |
|
278€ |
|
Pub |
BR244 Breast cancer tissue array with adjacent normal tissues, with TNM and grade info, 12 cases 24 cores, replaced by BR245 US Biomax 88 |
BR244 |
Breast cancer tissue array with adjacent normal tissues, with TNM and grade info, 12 cases 24 cores, replaced by BR245 |
US Biomax |
|
88€ |
|
Pub |
BN243 Multiple normal (12 type) tissue array, 12 cases 24 cores, replacing BN241 US Biomax 88 |
BN243 |
Multiple normal (12 type) tissue array, 12 cases 24 cores, replacing BN241 |
US Biomax |
|
88€ |
|
Pub |
T195a Prostate cancer test tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T195; ihc Anti-Actin confirmed US Biomax 105 |
T195a |
Prostate cancer test tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T195; ihc Anti-Actin confirmed |
US Biomax |
|
105€ |
|
Pub |
ES1002 Esophageal cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores US Biomax 266 |
ES1002 |
Esophageal cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores |
US Biomax |
|
266€ |
|
Pub |
CO722 Colon adenocarcinoma tissue array with matched tumor adjacent and adjacent normal tissue control, with stage and grade info, 24 cases 72 cores, replacing BC05021 US Biomax 231 |
CO722 |
Colon adenocarcinoma tissue array with matched tumor adjacent and adjacent normal tissue control, with stage and grade info, 24 cases 72 cores, replacing BC05021 |
US Biomax |
|
231€ |
|
Pub |
ME1001 Malignant melanoma, metastatic malignant melanoma and benign nevus tissue array, replaced by ME1003, 100 cases 100 cores US Biomax 266 |
ME1001 |
Malignant melanoma, metastatic malignant melanoma and benign nevus tissue array, replaced by ME1003, 100 cases 100 cores |
US Biomax |
|
266€ |
|
Pub |
CO484a Colon cancer tissue array with adjacent normal tissues, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing CO484; ihc Anti-Actin confirmed US Biomax 210 |
CO484a |
Colon cancer tissue array with adjacent normal tissues, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing CO484; ihc Anti-Actin confirmed |
US Biomax |
|
210€ |
|
Pub |
BS17015 Brain glioma tissue array, 63 cases 63 cores, replaced by GL803 US Biomax 231 |
BS17015 |
Brain glioma tissue array, 63 cases 63 cores, replaced by GL803 |
US Biomax |
|
231€ |
|
Pub |
T0013 Multiple organ cancer test tissue array, with normal tissue, including TNM and pathology grade, 6 cases 24 cores US Biomax 88 |
T0013 |
Multiple organ cancer test tissue array, with normal tissue, including TNM and pathology grade, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
CR803 Multiple (uterine cervix) cervical squamous cancer tissue array, 80 cases 80 cores, replacing BS10011 US Biomax 231 |
CR803 |
Multiple (uterine cervix) cervical squamous cancer tissue array, 80 cases 80 cores, replacing BS10011 |
US Biomax |
|
231€ |
|
Pub |
MS481a Mesothelioma tissue array with normal tissue as control, including TNM and clinical stage, 24 cases 48 cores, replacing MS481; ihc Anti-Actin confirmed US Biomax 296 |
MS481a |
Mesothelioma tissue array with normal tissue as control, including TNM and clinical stage, 24 cases 48 cores, replacing MS481; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
LM801a Lymphoma tissue array with adjacent normal lymph node and spleen tissue as control, 80 cases 80 cores, replacing LM801; ihc Anti-Actin confirmed US Biomax 267 |
LM801a |
Lymphoma tissue array with adjacent normal lymph node and spleen tissue as control, 80 cases 80 cores, replacing LM801; ihc Anti-Actin confirmed |
US Biomax |
|
267€ |
|
Pub |
BC000111 Multiple organ cancer tissue array, 39 cases 39 cores US Biomax 189 |
BC000111 |
Multiple organ cancer tissue array, 39 cases 39 cores |
US Biomax |
|
189€ |
|
Pub |
MC8010 Multiple organ cancer tissue array, including TNM and pathology grade, 80 cases 80 cores US Biomax 278 |
MC8010 |
Multiple organ cancer tissue array, including TNM and pathology grade, 80 cases 80 cores |
US Biomax |
|
278€ |
|
Pub |
BC05021 Colon adenocarcinoma (combination of adjacent and adjacent normal) tissue array, 18 cases 54 cores, no overlapping with BC05022, replaced by CO722 US Biomax 231 |
BC05021 |
Colon adenocarcinoma (combination of adjacent and adjacent normal) tissue array, 18 cases 54 cores, no overlapping with BC05022, replaced by CO722 |
US Biomax |
|
231€ |
|
Pub |
BR1503 Breast cancer tissue array, including TNM and pathology grade, with IHC results of Her 2, ER, PR, P53 and Ki 67, 75 cases 150 cores, replacing BR1502 US Biomax 278 |
BR1503 |
Breast cancer tissue array, including TNM and pathology grade, with IHC results of Her 2, ER, PR, P53 and Ki 67, 75 cases 150 cores, replacing BR1502 |
US Biomax |
|
278€ |
|
Pub |
T391 Mesothelioma test tissue array, with normal mesothelium tissue as control, including TNM and clinical stage, 6 cases 24 cores, replaced by T392 US Biomax 88 |
T391 |
Mesothelioma test tissue array, with normal mesothelium tissue as control, including TNM and clinical stage, 6 cases 24 cores, replaced by T392 |
US Biomax |
|
88€ |
|
Pub |
MNO661 Normal organ tissue array of human, 66 cases 66 cores US Biomax 189 |
MNO661 |
Normal organ tissue array of human, 66 cases 66 cores |
US Biomax |
|
189€ |
|
Pub |
LC807 Lung cancer and normal tissue array, with TNM and grade info, 77 cases 80 cores, replacing BC04014 US Biomax 231 |
LC807 |
Lung cancer and normal tissue array, with TNM and grade info, 77 cases 80 cores, replacing BC04014 |
US Biomax |
|
231€ |
|
Pub |
BL1001 Bladder cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 266 |
BL1001 |
Bladder cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores |
US Biomax |
|
266€ |
|
Pub |
MC245 Multiple cancer (12 type) and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing MC242 US Biomax 88 |
MC245 |
Multiple cancer (12 type) and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing MC242 |
US Biomax |
|
88€ |
|
Pub |
BRN801 Breast normal adjacent tissue and cancer tissue array, 80 cases 80 cores, replacing BN08013 US Biomax 231 |
BRN801 |
Breast normal adjacent tissue and cancer tissue array, 80 cases 80 cores, replacing BN08013 |
US Biomax |
|
231€ |
|
Pub |
BC03021 Liver carcinoma (combination of adjacent and normal) tissue array, 42 cases 63 cores, replaced by LV803 US Biomax 231 |
BC03021 |
Liver carcinoma (combination of adjacent and normal) tissue array, 42 cases 63 cores, replaced by LV803 |
US Biomax |
|
231€ |
|
Pub |
RA161 Multiple organs normal tissue array of rat, 8 cases 16 cores US Biomax 189 |
RA161 |
Multiple organs normal tissue array of rat, 8 cases 16 cores |
US Biomax |
|
189€ |
|
Pub |
PR953 Prostate cancer tissue array with matched normal adjacent tissue and metastatic bones, with TNM, Gleason scores, PSA level and survival data, 40 cases 95 cores, replaced by PR954 US Biomax 456 |
PR953 |
Prostate cancer tissue array with matched normal adjacent tissue and metastatic bones, with TNM, Gleason scores, PSA level and survival data, 40 cases 95 cores, replaced by PR954 |
US Biomax |
|
456€ |
|
Pub |
CO804 Multiple types of colon carcinoma tissue array (replacing BC05011), 80 cases 80 cores US Biomax 231 |
CO804 |
Multiple types of colon carcinoma tissue array (replacing BC05011), 80 cases 80 cores |
US Biomax |
|
231€ |
|
Pub |
ME2082a Malignant melanoma tissue array, including TNM and clinical stage, 208 cases 208 cores, replacing ME2082; ihc Anti-Actin confirmed US Biomax 429 |
ME2082a |
Malignant melanoma tissue array, including TNM and clinical stage, 208 cases 208 cores, replacing ME2082; ihc Anti-Actin confirmed |
US Biomax |
|
429€ |
|
Pub |
BC12011a Bladder cancer tissue array, including TNM, clinical stage and pathology grade, 63 cases 63 cores, replacing BC12011; ihc Anti-Actin confirmed US Biomax 162 |
BC12011a |
Bladder cancer tissue array, including TNM, clinical stage and pathology grade, 63 cases 63 cores, replacing BC12011; ihc Anti-Actin confirmed |
US Biomax |
|
162€ |
|
Pub |
T008 Multiple organ cancer test tissue array, with normal tissue, including TNM and pathology grade, 6 cases 24 cores US Biomax 88 |
T008 |
Multiple organ cancer test tissue array, with normal tissue, including TNM and pathology grade, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
PA242a Pancreas cancer tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing PA242; ihc Anti-Actin confirmed US Biomax 105 |
PA242a |
Pancreas cancer tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing PA242; ihc Anti-Actin confirmed |
US Biomax |
|
105€ |
|
Pub |
BN01011 Normal stomach tissue (multi sites) array, 21 cases 63 cores, replaced by BN01011b US Biomax 160 |
BN01011 |
Normal stomach tissue (multi sites) array, 21 cases 63 cores, replaced by BN01011b |
US Biomax |
|
160€ |
|
Pub |
PR241 Prostate cancer test tissue array with unmatched normal adjacent tissue, 12 cases 24 cores, replaced by PR243 US Biomax 88 |
PR241 |
Prostate cancer test tissue array with unmatched normal adjacent tissue, 12 cases 24 cores, replaced by PR243 |
US Biomax |
|
88€ |
|
Pub |
LV805 Liver cirrhosis and hepatitis tissue array, 80 cases 80 cores, replacing IC03001 US Biomax 231 |
LV805 |
Liver cirrhosis and hepatitis tissue array, 80 cases 80 cores, replacing IC03001 |
US Biomax |
|
231€ |
|
Pub |
LC10010 Small cell lung carcinoma tissue array, for antibody screening, including TNM and clinical stage, 50 cases 100 cores US Biomax 231 |
LC10010 |
Small cell lung carcinoma tissue array, for antibody screening, including TNM and clinical stage, 50 cases 100 cores |
US Biomax |
|
231€ |
|
Pub |
OS804 Osteosarcoma tissue tissue array, with stage and grade, 40 cases 80 cores, replacing BS26011 US Biomax 266 |
OS804 |
Osteosarcoma tissue tissue array, with stage and grade, 40 cases 80 cores, replacing BS26011 |
US Biomax |
|
266€ |
|
Pub |
SK244 Age grouped female skin tissue array, 12 cases 24 cores, replacing SK243 US Biomax 99 |
SK244 |
Age grouped female skin tissue array, 12 cases 24 cores, replacing SK243 |
US Biomax |
|
99€ |
|
Pub |
CR244 Uterine cervix cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 12 cases 24 cores, replacing CR241 US Biomax 189 |
CR244 |
Uterine cervix cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 12 cases 24 cores, replacing CR241 |
US Biomax |
|
189€ |
|
Pub |
IQ417 Mouse Anti-Human Fibronectin Target Antigen Fibronectin Host Isotype Mouse IgG1 Application IHC (P); Immunohistochemical staining of matrix fibronectin in normal and malignant tissues on frozen sec Imunquest 0.1ml (1mg/ml) 492 |
IQ417 |
Mouse Anti-Human Fibronectin Target Antigen Fibronectin Host Isotype Mouse IgG1 Application IHC (P); Immunohistochemical staining of matrix fibronectin in normal and malignant tissues on frozen sec |
Imunquest |
0.1ml (1mg/ml) |
492€ |
|
Pub |
T086a Breast invasive ductal carcinoma test tissue array, with normal tissue, including TNM and pathology grade, 12 cases 24 cores, replaced by T086b; ihc Anti-Actin confirmed US Biomax 90 |
T086a |
Breast invasive ductal carcinoma test tissue array, with normal tissue, including TNM and pathology grade, 12 cases 24 cores, replaced by T086b; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
ES722 Esophageal cancer and adjacent tissue array, with stage and grade info, 30 cases 72 cores, replacing BC02023 US Biomax 231 |
ES722 |
Esophageal cancer and adjacent tissue array, with stage and grade info, 30 cases 72 cores, replacing BC02023 |
US Biomax |
|
231€ |
|
Pub |
ME802 Malignant melanoma with normal skin tissue array, 40 cases 80 cores, replacing BS38011 US Biomax 266 |
ME802 |
Malignant melanoma with normal skin tissue array, 40 cases 80 cores, replacing BS38011 |
US Biomax |
|
266€ |
|
Pub |
BC19017 Prostate carcinoma tissue array, 33 cases 63 cores, replaced by PR809 US Biomax 160 |
BC19017 |
Prostate carcinoma tissue array, 33 cases 63 cores, replaced by PR809 |
US Biomax |
|
160€ |
|
Pub |
PA802 Multiple pancreatic cancer tissue array with unmatched normal tissues, with TNM data, 78 cases 80 cores, replacing PA801, to be replaced by PA805 US Biomax 266 |
PA802 |
Multiple pancreatic cancer tissue array with unmatched normal tissues, with TNM data, 78 cases 80 cores, replacing PA801, to be replaced by PA805 |
US Biomax |
|
266€ |
|
Pub |
BR953 Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER PR p53 IHC results and survival data, 31 cases 95 cores, replacing BR952 US Biomax 456 |
BR953 |
Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER PR p53 IHC results and survival data, 31 cases 95 cores, replacing BR952 |
US Biomax |
|
456€ |
|
Pub |
GIP541 Visceral peritoneum tissue array, 27 cases 54 cores US Biomax 173 |
GIP541 |
Visceral peritoneum tissue array, 27 cases 54 cores |
US Biomax |
|
173€ |
|
Pub |
NHL803b Lymphoma tissue array, 80 cases 80 cores, replacing NHL803 US Biomax 321 |
NHL803b |
Lymphoma tissue array, 80 cases 80 cores, replacing NHL803 |
US Biomax |
|
321€ |
|
Pub |
KD1001 Kidney cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 231 |
KD1001 |
Kidney cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores |
US Biomax |
|
231€ |
|
Pub |
PR8010 Prostate cancer tissue array, including TNM and pathology grade, 80 cases 80 cores, replacing PR802 US Biomax 266 |
PR8010 |
Prostate cancer tissue array, including TNM and pathology grade, 80 cases 80 cores, replacing PR802 |
US Biomax |
|
266€ |
|
Pub |
BS06031 Rectum adenocarcinoma (grade II) tissue array, 21 cases 63 cores, replaced by RE723 US Biomax 160 |
BS06031 |
Rectum adenocarcinoma (grade II) tissue array, 21 cases 63 cores, replaced by RE723 |
US Biomax |
|
160€ |
|
Pub |
BC081115 Breast cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 110 cases 110 cores, replaced by BC081120 US Biomax 278 |
BC081115 |
Breast cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 110 cases 110 cores, replaced by BC081120 |
US Biomax |
|
278€ |
|
Pub |
PA1002 Pancreas cancer tissue array for antibody screening, with normal tissue, including TNM and pathology grade, 50 cases 100 cores US Biomax 266 |
PA1002 |
Pancreas cancer tissue array for antibody screening, with normal tissue, including TNM and pathology grade, 50 cases 100 cores |
US Biomax |
|
266€ |
|
Pub |
CR602 Tissue array of uterine cervical disease spectrum (cervical cancer, CIN, inflammation and adjacent normal tissue), 60 cases 60 cores, replacing CR601 US Biomax 231 |
CR602 |
Tissue array of uterine cervical disease spectrum (cervical cancer, CIN, inflammation and adjacent normal tissue), 60 cases 60 cores, replacing CR601 |
US Biomax |
|
231€ |
|
Pub |
MO32011 Mouse spleen tissue array, 100 cases 100 cores, 50 male and 50 female, replaced by MO1002 US Biomax 189 |
MO32011 |
Mouse spleen tissue array, 100 cases 100 cores, 50 male and 50 female, replaced by MO1002 |
US Biomax |
|
189€ |
|
Pub |
BL806 Bladder cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 80 cases 80 cores, replacing BL801 US Biomax 266 |
BL806 |
Bladder cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 80 cases 80 cores, replacing BL801 |
US Biomax |
|
266€ |
|
Pub |
CO1002 Colon and rectum carcinoma and normal tissue array, 73 cases 100 cores, replaced by CO1002b US Biomax 278 |
CO1002 |
Colon and rectum carcinoma and normal tissue array, 73 cases 100 cores, replaced by CO1002b |
US Biomax |
|
278€ |
|
Pub |
BC04119b Lung adenocarcinoma tissue array with normal lung tissue, including TNM and pathology grade,30 cases 40 cores, replacing BC04119 US Biomax 336 |
BC04119b |
Lung adenocarcinoma tissue array with normal lung tissue, including TNM and pathology grade,30 cases 40 cores, replacing BC04119 |
US Biomax |
|
336€ |
|
Pub |
ST721 Stomach adenocarcinoma and normal tissue array with TNM and pathology grade data, 24 cases 72 cores, replacing BC01011 US Biomax 231 |
ST721 |
Stomach adenocarcinoma and normal tissue array with TNM and pathology grade data, 24 cases 72 cores, replacing BC01011 |
US Biomax |
|
231€ |
|
Pub |
BR243b Breast invasive ductal carcinoma tissue array with matched adjacent normal breast tissue, including TNM and pathology grade, 6 cases 24 cores, replacing BR243; ihc Anti-Actin confirmed US Biomax 90 |
BR243b |
Breast invasive ductal carcinoma tissue array with matched adjacent normal breast tissue, including TNM and pathology grade, 6 cases 24 cores, replacing BR243; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
BC27011 Multiple organs, diseased tissue array of oral cavity, 47 cases 48 cores US Biomax 189 |
BC27011 |
Multiple organs, diseased tissue array of oral cavity, 47 cases 48 cores |
US Biomax |
|
189€ |
|
Pub |
T044 Lung cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replaced by T045 US Biomax 88 |
T044 |
Lung cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replaced by T045 |
US Biomax |
|
88€ |
|
Pub |
T054 Colon tumor test tissue array, with normal control tissue, including TNM and pathology grade, 12 cases 24 cores, replacing T052 US Biomax 88 |
T054 |
Colon tumor test tissue array, with normal control tissue, including TNM and pathology grade, 12 cases 24 cores, replacing T052 |
US Biomax |
|
88€ |
|
Pub |
RE722 Rectal cancer tissue array with matched adjacent normal tissue, including stage and grade info, 24 cases 72 cores, replacing BC06022 US Biomax 231 |
RE722 |
Rectal cancer tissue array with matched adjacent normal tissue, including stage and grade info, 24 cases 72 cores, replacing BC06022 |
US Biomax |
|
231€ |
|
Pub |
MC2082 Multiple organ tumor tissue array, including TNM, clinical stage and pathology grade, 208 cases 208 cores US Biomax 456 |
MC2082 |
Multiple organ tumor tissue array, including TNM, clinical stage and pathology grade, 208 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
TH802a Thyroid cancer and adenoma tissue array, including TNM and clinical stage, 80 cases 80 cores, replacing TH802; ihc Anti-Actin confirmed US Biomax 267 |
TH802a |
Thyroid cancer and adenoma tissue array, including TNM and clinical stage, 80 cases 80 cores, replacing TH802; ihc Anti-Actin confirmed |
US Biomax |
|
267€ |
|
Pub |
BN482 Normal human tissue microarray from 12 organs from autopsy, 24 cases 48 cores US Biomax 160 |
BN482 |
Normal human tissue microarray from 12 organs from autopsy, 24 cases 48 cores |
US Biomax |
|
160€ |
|
Pub |
PR807a Prostate cancer, hyperplasia and normal tissue array, including TNM and pathology grade, 79 cases 80 cores, replacing PR807; ihc Anti-Prostate Specific Antigen (PSA) confirmed US Biomax 296 |
PR807a |
Prostate cancer, hyperplasia and normal tissue array, including TNM and pathology grade, 79 cases 80 cores, replacing PR807; ihc Anti-Prostate Specific Antigen (PSA) confirmed |
US Biomax |
|
296€ |
|
Pub |
CO726 Metastatic colon carcinoma tissue array, 24 cases 72 cores, replacing BC050112 US Biomax 266 |
CO726 |
Metastatic colon carcinoma tissue array, 24 cases 72 cores, replacing BC050112 |
US Biomax |
|
266€ |
|
Pub |
ME1004a Malignant melanoma, metastatic malignant melanoma and nevus tissue array, including TNM and clinical stage, 100 cases 100 cores, replacing ME1004; ihc Anti-Actin confirmed US Biomax 296 |
ME1004a |
Malignant melanoma, metastatic malignant melanoma and nevus tissue array, including TNM and clinical stage, 100 cases 100 cores, replacing ME1004; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
BS17018 Brain glioblastoma tissue array, 33 cases 63 cores, replaced by GL805 US Biomax 231 |
BS17018 |
Brain glioblastoma tissue array, 33 cases 63 cores, replaced by GL805 |
US Biomax |
|
231€ |
|
Pub |
T003 Multiple organ cancer and normal tissue array, including TNM and pathology grade, 6 cases 24 cores US Biomax 88 |
T003 |
Multiple organ cancer and normal tissue array, including TNM and pathology grade, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
QAM-CAA-3000-SW Q-Analyzer Software for QAM-CAA-3000 Antibody Array Ray Biotech 4 modules 1030 |
QAM-CAA-3000-SW |
Q-Analyzer Software for QAM-CAA-3000 Antibody Array |
Ray Biotech |
4 modules |
1030€ |
|
Pub |
BR802b Breast invasive ductal carcinoma with matched or unmatched adjacent normal breast tissue array, including TNM and pathology grade, 47cases 80cores, replacing BR802 US Biomax 266 |
BR802b |
Breast invasive ductal carcinoma with matched or unmatched adjacent normal breast tissue array, including TNM and pathology grade, 47cases 80cores, replacing BR802 |
US Biomax |
|
266€ |
|
Pub |
BS01032 Stomach adenocarcinoma (grade II) tissue array, 63 cases 63 cores, replaced by ST808 US Biomax 160 |
BS01032 |
Stomach adenocarcinoma (grade II) tissue array, 63 cases 63 cores, replaced by ST808 |
US Biomax |
|
160€ |
|
Pub |
PR243a Prostate cancer tissue array with adjacent normal prostate tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing PR243; ihc Anti-Actin confirmed US Biomax 105 |
PR243a |
Prostate cancer tissue array with adjacent normal prostate tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing PR243; ihc Anti-Actin confirmed |
US Biomax |
|
105€ |
|
Pub |
LV809 Hepatocellular carcinoma and normal tissue array, with stage, TNM and grade, 80 cases 80 cores, replacing BS03014 US Biomax 231 |
LV809 |
Hepatocellular carcinoma and normal tissue array, with stage, TNM and grade, 80 cases 80 cores, replacing BS03014 |
US Biomax |
|
231€ |
|
Pub |
BS03014 Hepatocellular carcinoma tissue array, 63 cases 63 cores, replaced by LV809 US Biomax 160 |
BS03014 |
Hepatocellular carcinoma tissue array, 63 cases 63 cores, replaced by LV809 |
US Biomax |
|
160€ |
|
Pub |
LC10013 Lung adenocarcinoma tissue array with adjacent normal lung tissue, including TNM and pathology grade, 50 cases 100 cores, replacing LC1002 US Biomax 266 |
LC10013 |
Lung adenocarcinoma tissue array with adjacent normal lung tissue, including TNM and pathology grade, 50 cases 100 cores, replacing LC1002 |
US Biomax |
|
266€ |
|
Pub |
HN242a Head and neck cancer tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing HN242; ihc Anti-Actin confirmed US Biomax 90 |
HN242a |
Head and neck cancer tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing HN242; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
BC07012 Kidney carcinoma (multi tissue combined panel) tissue array, 72 cases 72 cores, replaced by BC07015 US Biomax 160 |
BC07012 |
Kidney carcinoma (multi tissue combined panel) tissue array, 72 cases 72 cores, replaced by BC07015 |
US Biomax |
|
160€ |
|
Pub |
T082 Breast cancer test tissue array, with normal tissue as control, including TNM, stage and grade, 12 cases 24 cores, replaced by T084 US Biomax 88 |
T082 |
Breast cancer test tissue array, with normal tissue as control, including TNM, stage and grade, 12 cases 24 cores, replaced by T084 |
US Biomax |
|
88€ |
|
Pub |
OV241a Ovary cancer and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing OV241; ihc Anti-Actin confirmed US Biomax 105 |
OV241a |
Ovary cancer and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing OV241; ihc Anti-Actin confirmed |
US Biomax |
|
105€ |
|
Pub |
PA483a Pancreatic cancer tissue array, including TNM and pathology grade, 48 cases 48 cores, replacing PA483; ihc Anti-Actin confirmed US Biomax 185 |
PA483a |
Pancreatic cancer tissue array, including TNM and pathology grade, 48 cases 48 cores, replacing PA483; ihc Anti-Actin confirmed |
US Biomax |
|
185€ |
|
Pub |
BN04011 Normal lung tissue (multi sites) tissue array, 22 cases 63 cores, replaced by LC725 US Biomax 160 |
BN04011 |
Normal lung tissue (multi sites) tissue array, 22 cases 63 cores, replaced by LC725 |
US Biomax |
|
160€ |
|
Pub |
BC001130 Pancreatic carcinoma and multi organ adjacent tissue array, including TNM, clinical stage and pathology grade, 81 cases 121 cores US Biomax 278 |
BC001130 |
Pancreatic carcinoma and multi organ adjacent tissue array, including TNM, clinical stage and pathology grade, 81 cases 121 cores |
US Biomax |
|
278€ |
|
Pub |
BR963 Breast disease spectrum tissue array, including TNM and pathology grade, stage, TNM and IHC markers (AR, PR, ER, Her 2, Ki67, CK14 and p53), 48 cases 96 cores, replacing BR962 US Biomax 314 |
BR963 |
Breast disease spectrum tissue array, including TNM and pathology grade, stage, TNM and IHC markers (AR, PR, ER, Her 2, Ki67, CK14 and p53), 48 cases 96 cores, replacing BR962 |
US Biomax |
|
314€ |
|
Pub |
T173a Brain cancer test tissue array, with normal tissue as control, including TNM and pathology grade, 2 serial sections, 6 cases 24 cores, replacing T173; ihc Anti-Actin confirmed US Biomax 90 |
T173a |
Brain cancer test tissue array, with normal tissue as control, including TNM and pathology grade, 2 serial sections, 6 cases 24 cores, replacing T173; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
BC01014 Stomach carcinoma tissue array (multi tissue combined panel), 71 cases 72 cores, replaced by ST807 US Biomax 231 |
BC01014 |
Stomach carcinoma tissue array (multi tissue combined panel), 71 cases 72 cores, replaced by ST807 |
US Biomax |
|
231€ |
|
Pub |
OV1004 Ovarian cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores US Biomax 231 |
OV1004 |
Ovarian cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores |
US Biomax |
|
231€ |
|
Pub |
CO241a Colon cancer tissue array with adjacent normal colon tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replacing CO241; ihc Anti-Actin confirmed US Biomax 105 |
CO241a |
Colon cancer tissue array with adjacent normal colon tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replacing CO241; ihc Anti-Actin confirmed |
US Biomax |
|
105€ |
|
Pub |
BS05021 Colon adenocarcinoma (grade I) tissue array, 23 cases 63 cores, replaced by CO723 US Biomax 160 |
BS05021 |
Colon adenocarcinoma (grade I) tissue array, 23 cases 63 cores, replaced by CO723 |
US Biomax |
|
160€ |
|
Pub |
BC08015 Breast carcinoma (multi tissue combined panel) tissue array, 22 cases 63 cores, replaced by BR728 US Biomax 160 |
BC08015 |
Breast carcinoma (multi tissue combined panel) tissue array, 22 cases 63 cores, replaced by BR728 |
US Biomax |
|
160€ |
|
Pub |
BL801 Bladder cancer tissue array, with adjacent normal tissue, pathology grade and TNM stage, 53 cases 80 cores, replaced by BL806 US Biomax 266 |
BL801 |
Bladder cancer tissue array, with adjacent normal tissue, pathology grade and TNM stage, 53 cases 80 cores, replaced by BL806 |
US Biomax |
|
266€ |
|
Pub |
ES8010 Esophageal cancer and adjacent normal tissue array, with TNM and grade info, 40 cases 80 cores, replacing ES801 US Biomax 231 |
ES8010 |
Esophageal cancer and adjacent normal tissue array, with TNM and grade info, 40 cases 80 cores, replacing ES801 |
US Biomax |
|
231€ |
|
Pub |
BC21011 Skin malignant tumor tissue array, 78 cases 78 cores (squamous carcinoma, adenocarcinoma, basal cell carcinoma, sarcoma, melanoma), replaced by BC21014 US Biomax 231 |
BC21011 |
Skin malignant tumor tissue array, 78 cases 78 cores (squamous carcinoma, adenocarcinoma, basal cell carcinoma, sarcoma, melanoma), replaced by BC21014 |
US Biomax |
|
231€ |
|
Pub |
AMS544 Mouse normal tissue array, covering 22 organ anatomic sites, 3 cases 54 cores US Biomax 225 |
AMS544 |
Mouse normal tissue array, covering 22 organ anatomic sites, 3 cases 54 cores |
US Biomax |
|
225€ |
|
Pub |
PA805a Pancreas cancer tissue array with adjacent normal tissue as control, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing PA805; ihc Anti-Actin confirmed US Biomax 296 |
PA805a |
Pancreas cancer tissue array with adjacent normal tissue as control, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing PA805; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
BR243f Breast cancer tissue array with matched adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replacing BR243a; ihc Anti-Actin confirmed US Biomax 90 |
BR243f |
Breast cancer tissue array with matched adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replacing BR243a; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
BC34111 Multiple head and neck squamous cell carcinoma tissue array with normal tissue, 36 cases 72 cores, replaced by HN811 US Biomax 160 |
BC34111 |
Multiple head and neck squamous cell carcinoma tissue array with normal tissue, 36 cases 72 cores, replaced by HN811 |
US Biomax |
|
160€ |
|
Pub |
CyFDA FDA normal organ tissue array of cynomolgus monkey, 99 cases 99 cores US Biomax 314 |
CyFDA |
FDA normal organ tissue array of cynomolgus monkey, 99 cases 99 cores |
US Biomax |
|
314€ |
|
Pub |
GL241a Brain tumor tissue array with adjacent normal brain tissue, including pathology grade, 10 cases 24 cores, replacing GL241; ihc Anti-Actin confirmed US Biomax 90 |
GL241a |
Brain tumor tissue array with adjacent normal brain tissue, including pathology grade, 10 cases 24 cores, replacing GL241; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T195 Prostate adenocarcinoma tissue array, including TNM and pathology grade, 12 cases 24 cores, 2 serial sections, replacing T192 US Biomax 113 |
T195 |
Prostate adenocarcinoma tissue array, including TNM and pathology grade, 12 cases 24 cores, 2 serial sections, replacing T192 |
US Biomax |
|
113€ |
|
Pub |
ES1001 Esophagus cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 266 |
ES1001 |
Esophagus cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores |
US Biomax |
|
266€ |
|
Pub |
PR803a Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing PR803; ihc Anti-Actin confirmed US Biomax 296 |
PR803a |
Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing PR803; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
BS17011 Brain glioblastoma tissue array, 21 cases 63 cores, replaced by GL811 US Biomax 231 |
BS17011 |
Brain glioblastoma tissue array, 21 cases 63 cores, replaced by GL811 |
US Biomax |
|
231€ |
|
Pub |
T0012 Multiple organ cancer test tissue array, with normal tissue, including TNM and pathology grade, 6 cases 24 cores US Biomax 88 |
T0012 |
Multiple organ cancer test tissue array, with normal tissue, including TNM and pathology grade, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
BR8015 Breast cancer tissue array, with adjacent normal tissue and normal tissue, including TNM and pathology grade, 80 cases 80 cores, replacing BC08014 US Biomax 231 |
BR8015 |
Breast cancer tissue array, with adjacent normal tissue and normal tissue, including TNM and pathology grade, 80 cases 80 cores, replacing BC08014 |
US Biomax |
|
231€ |
|
Pub |
BM01011 Liver, kidney, lung, muscle, brain, heart, stomach, spleen tissue array, 160 cases 160 cores, replaced by MO1601 US Biomax 278 |
BM01011 |
Liver, kidney, lung, muscle, brain, heart, stomach, spleen tissue array, 160 cases 160 cores, replaced by MO1601 |
US Biomax |
|
278€ |
|
Pub |
MC801 Multiple cancer tissue array, replacing BC00012, 80 cases 80 cores, with grade information US Biomax 266 |
MC801 |
Multiple cancer tissue array, replacing BC00012, 80 cases 80 cores, with grade information |
US Biomax |
|
266€ |
|
Pub |
LV723 Liver cancer and adjacent normal tissue array, including TNM and pathology grade, 72 cases 72 cores, replacing BC03013 US Biomax 231 |
LV723 |
Liver cancer and adjacent normal tissue array, including TNM and pathology grade, 72 cases 72 cores, replacing BC03013 |
US Biomax |
|
231€ |
|
Pub |
BR10010a Breast cancer and matched metastatic carcinoma tissue array, including TNM and pathology grade, with ER, PR and Her-2 (neu) IHC results, 50 cases 100 cores, replacing BR10010; ihc Anti-Actin confirme US Biomax 296 |
BR10010a |
Breast cancer and matched metastatic carcinoma tissue array, including TNM and pathology grade, with ER, PR and Her-2 (neu) IHC results, 50 cases 100 cores, replacing BR10010; ihc Anti-Actin confirme |
US Biomax |
|
296€ |
|
Pub |
LC724 Lung cancer and adjacent normal tissue array, with TNM and grade info, 24 cases 72 cores, replacing BS04031 US Biomax 231 |
LC724 |
Lung cancer and adjacent normal tissue array, with TNM and grade info, 24 cases 72 cores, replacing BS04031 |
US Biomax |
|
231€ |
|
Pub |
LC806 Multiple types of lung carcinoma tissue array, 80 cases 80 cores, replacing BC04013 US Biomax 231 |
LC806 |
Multiple types of lung carcinoma tissue array, 80 cases 80 cores, replacing BC04013 |
US Biomax |
|
231€ |
|
Pub |
BE01015 Multiple organ, normal fetus tissue array, 50 cases 50 cores US Biomax 189 |
BE01015 |
Multiple organ, normal fetus tissue array, 50 cases 50 cores |
US Biomax |
|
189€ |
|
Pub |
GL803a Brain tumor and adjacent normal tissue array, including pathology grade, 80 cases 80 cores, replacing GL803; ihc Anti-Actin confirmed US Biomax 296 |
GL803a |
Brain tumor and adjacent normal tissue array, including pathology grade, 80 cases 80 cores, replacing GL803; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
T212a Skin tumor tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T212; ihc Anti-Actin confirmed US Biomax 90 |
T212a |
Skin tumor tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T212; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
BC03013 Liver carcinoma (multi tissue combined panel) tissue array, 63 cases 63 cores, replaced by LV723 US Biomax 160 |
BC03013 |
Liver carcinoma (multi tissue combined panel) tissue array, 63 cases 63 cores, replaced by LV723 |
US Biomax |
|
160€ |
|
Pub |
ST1004 Stomach adenocarcinoma with matched adjacent tissue array, including TNM and pathology grade, 55 cases 100 cores, replacing BC01114; ihc Anti-Actin confirmed US Biomax 258 |
ST1004 |
Stomach adenocarcinoma with matched adjacent tissue array, including TNM and pathology grade, 55 cases 100 cores, replacing BC01114; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
PR952 Prostate adenocarcinoma tissue array with matched normal adjacent tissue and metastatic bones, 40 cases 95 cores, with TNM and Gleason scores, replaced by PR953 US Biomax 314 |
PR952 |
Prostate adenocarcinoma tissue array with matched normal adjacent tissue and metastatic bones, 40 cases 95 cores, with TNM and Gleason scores, replaced by PR953 |
US Biomax |
|
314€ |
|
Pub |
CO702 Colon cancer tissue array, with metastasis tissue and adjacent normal tissue, including TNM and pathology grade, 69 cases 69 cores, repalcing BC05115 US Biomax 266 |
CO702 |
Colon cancer tissue array, with metastasis tissue and adjacent normal tissue, including TNM and pathology grade, 69 cases 69 cores, repalcing BC05115 |
US Biomax |
|
266€ |
|
Pub |
T007 Multiple organ cancer test tissue array, with normal tissue, including TNM and pathology grade, 6 cases 24 cores US Biomax 88 |
T007 |
Multiple organ cancer test tissue array, with normal tissue, including TNM and pathology grade, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
BR804a Breast cancer tissue array, including TNM, clinical stage and pathology grade, 40 cases 80 cores, replacing BR804; ihc Anti-Actin confirmed US Biomax 267 |
BR804a |
Breast cancer tissue array, including TNM, clinical stage and pathology grade, 40 cases 80 cores, replacing BR804; ihc Anti-Actin confirmed |
US Biomax |
|
267€ |
|
Pub |
LV804 Liver cancer tissue array with normal tissue from autopsy, 38 cases 80 cores, replacing BS03011 US Biomax 231 |
LV804 |
Liver cancer tissue array with normal tissue from autopsy, 38 cases 80 cores, replacing BS03011 |
US Biomax |
|
231€ |
|
Pub |
BS02031 Esophagus squamous cell carcinoma (grade II) tissue array, 22 cases 63 cores, replaced by ES723 US Biomax 160 |
BS02031 |
Esophagus squamous cell carcinoma (grade II) tissue array, 22 cases 63 cores, replaced by ES723 |
US Biomax |
|
160€ |
|
Pub |
UT1002 Endometrium cancer tissue array for antibody screening, including TNM and pathology grade, 50 cases 100 cores US Biomax 266 |
UT1002 |
Endometrium cancer tissue array for antibody screening, including TNM and pathology grade, 50 cases 100 cores |
US Biomax |
|
266€ |
|
Pub |
BR1502 Breast cancer mid density tissue array, wiht AR ER PR Her 2 P53 EGFR Ki67 IHC results, 75 cases 150 cores, replaced by BR1503 US Biomax 278 |
BR1502 |
Breast cancer mid density tissue array, wiht AR ER PR Her 2 P53 EGFR Ki67 IHC results, 75 cases 150 cores, replaced by BR1503 |
US Biomax |
|
278€ |
|
Pub |
PR483a Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing PR483; ihc Anti-Actin confirmed US Biomax 210 |
PR483a |
Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing PR483; ihc Anti-Actin confirmed |
US Biomax |
|
210€ |
|
Pub |
OS803 Chondrosarcoma tissue tissue array, 27 cases 80 cores, replacing BS36011 US Biomax 266 |
OS803 |
Chondrosarcoma tissue tissue array, 27 cases 80 cores, replacing BS36011 |
US Biomax |
|
266€ |
|
Pub |
BS04071 Lung squamous cell carcinoma (grade III) tissue array, 21 cases 63 cores, replaced by LC723 US Biomax 160 |
BS04071 |
Lung squamous cell carcinoma (grade III) tissue array, 21 cases 63 cores, replaced by LC723 |
US Biomax |
|
160€ |
|
Pub |
LC1006 Non small cell lung carcinoma (NSCLC) tissue array with matched adjacent normal tissue as control, 56 cases 100 cores, with stage and grade data, replacing LC1001 US Biomax 231 |
LC1006 |
Non small cell lung carcinoma (NSCLC) tissue array with matched adjacent normal tissue as control, 56 cases 100 cores, with stage and grade data, replacing LC1001 |
US Biomax |
|
231€ |
|
Pub |
BC07015 Multiple type kidney cancer tissue array with normal tissues, 71 cases 72 cores, replacing BC07012 US Biomax 231 |
BC07015 |
Multiple type kidney cancer tissue array with normal tissues, 71 cases 72 cores, replacing BC07012 |
US Biomax |
|
231€ |
|
Pub |
SK243 Age grouped female skin tissue array, 12 cases 24 cores, replaced by SK244 US Biomax 231 |
SK243 |
Age grouped female skin tissue array, 12 cases 24 cores, replaced by SK244 |
US Biomax |
|
231€ |
|
Pub |
QAH-CAA-3000-SW Q-Analyzer Software for QAH-CAA-3000 Antibody Array Ray Biotech 4 modules 1030 |
QAH-CAA-3000-SW |
Q-Analyzer Software for QAH-CAA-3000 Antibody Array |
Ray Biotech |
4 modules |
1030€ |
|
Pub |
MO1002 Mouse spleen tissue array, 100 cases 100 cores, 50 male and 50 female, replacing MO32011 US Biomax 189 |
MO1002 |
Mouse spleen tissue array, 100 cases 100 cores, 50 male and 50 female, replacing MO32011 |
US Biomax |
|
189€ |
|
Pub |
T086 Breast cancer test tissue array, with normal tissue, including TNM and pathology grade, 12 cases 24 cores, replacing T084 US Biomax 88 |
T086 |
Breast cancer test tissue array, with normal tissue, including TNM and pathology grade, 12 cases 24 cores, replacing T084 |
US Biomax |
|
88€ |
|
Pub |
BC04014 Non small cell lung carcinoma (NSCLC) tissue array, 63 cases 63 cores, replaced by LC807 US Biomax 160 |
BC04014 |
Non small cell lung carcinoma (NSCLC) tissue array, 63 cases 63 cores, replaced by LC807 |
US Biomax |
|
160€ |
|
Pub |
ST2091 Stomach cancer tissue array with adjacent normal stomach tissue, including TNM and clinical stage, 208 cases 208 cores, replacing ST2001; ihc Anti-Actin confirmed US Biomax 487 |
ST2091 |
Stomach cancer tissue array with adjacent normal stomach tissue, including TNM and clinical stage, 208 cases 208 cores, replacing ST2001; ihc Anti-Actin confirmed |
US Biomax |
|
487€ |
|
Pub |
ME801 Malignant melanoma tissue array, 80 cases 80 cores, replaced by ME804 US Biomax 231 |
ME801 |
Malignant melanoma tissue array, 80 cases 80 cores, replaced by ME804 |
US Biomax |
|
231€ |
|
Pub |
BR2086 Breast cancer and normal tissue array, including TNM, clinical stage and pathology grade, 208 cases 208 cores, replacing BR2001 US Biomax 456 |
BR2086 |
Breast cancer and normal tissue array, including TNM, clinical stage and pathology grade, 208 cases 208 cores, replacing BR2001 |
US Biomax |
|
456€ |
|
Pub |
T392 Mesothelioma test tissue array, with normal mesothelial control tissue, including TNM and clinical stage, 6 cases 24 cores, replacing T391 US Biomax 88 |
T392 |
Mesothelioma test tissue array, with normal mesothelial control tissue, including TNM and clinical stage, 6 cases 24 cores, replacing T391 |
US Biomax |
|
88€ |
|
Pub |
FDA992 FDA normal organ tissue array of human tissue, 67cases 100 cores US Biomax 278 |
FDA992 |
FDA normal organ tissue array of human tissue, 67cases 100 cores |
US Biomax |
|
278€ |
|
Pub |
PA801 Multiple pancreatic cancer tissue array with unmatched normal adjacent tissue, with stage and grade info, 70 cases 80 cores, replaced by PA802 US Biomax 231 |
PA801 |
Multiple pancreatic cancer tissue array with unmatched normal adjacent tissue, with stage and grade info, 70 cases 80 cores, replaced by PA802 |
US Biomax |
|
231€ |
|
Pub |
NHL803 Lymphoma tissue array, 80 cases 80 cores, replacing LM802 US Biomax 266 |
NHL803 |
Lymphoma tissue array, 80 cases 80 cores, replacing LM802 |
US Biomax |
|
266€ |
|
Pub |
BN115 Multiple organ normal tissue array, 46 cases 46 cores US Biomax 189 |
BN115 |
Multiple organ normal tissue array, 46 cases 46 cores |
US Biomax |
|
189€ |
|
Pub |
EN801a Endocrine cancer tissue array, including TNM and clinical stage, 40 cases 80 cores, replacing EN801; ihc Anti-Actin confirmed US Biomax 296 |
EN801a |
Endocrine cancer tissue array, including TNM and clinical stage, 40 cases 80 cores, replacing EN801; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
PR801 Prostate cancer tissue array with unmatched normal prostate tissue, 78 cases 80 cores, replaced by PR803 US Biomax 231 |
PR801 |
Prostate cancer tissue array with unmatched normal prostate tissue, 78 cases 80 cores, replaced by PR803 |
US Biomax |
|
231€ |
|
Pub |
CO243a Colon carcinoma tissue array with matched adjacent normal colon tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing CO243; ihc Anti-Actin confirmed US Biomax 105 |
CO243a |
Colon carcinoma tissue array with matched adjacent normal colon tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing CO243; ihc Anti-Actin confirmed |
US Biomax |
|
105€ |
|
Pub |
LY1001a Diffuse large-B cell lymphoma tissue array, 100 cases 100 cores, replacing LY1001; ihc Anti-Actin confirmed US Biomax 296 |
LY1001a |
Diffuse large-B cell lymphoma tissue array, 100 cases 100 cores, replacing LY1001; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
SK801b Skin squamous cell carcinoma tissue array, including TNM and pathology grade, 80 cases 80 cores, replacing SK801 US Biomax 321 |
SK801b |
Skin squamous cell carcinoma tissue array, including TNM and pathology grade, 80 cases 80 cores, replacing SK801 |
US Biomax |
|
321€ |
|
Pub |
CR601 Cervical carcinoma tissue array with cervical disease spectrum (normal, inflammation, CIN, malignant I III), 59 cases 60 cores, replaced by CR602 US Biomax 231 |
CR601 |
Cervical carcinoma tissue array with cervical disease spectrum (normal, inflammation, CIN, malignant I III), 59 cases 60 cores, replaced by CR602 |
US Biomax |
|
231€ |
|
Pub |
MC6163 High-density tissue array of multiple organ tumor and normal tissue, with pathology grade, cllinical stage and TNM, 616 cases 616 cores; ihc Anti-Actin confirmed US Biomax 811 |
MC6163 |
High-density tissue array of multiple organ tumor and normal tissue, with pathology grade, cllinical stage and TNM, 616 cases 616 cores; ihc Anti-Actin confirmed |
US Biomax |
|
811€ |
|
Pub |
BR041 Breast cancer tissue array with HER2 IHC control, including TNM and pathology grade, 4 cases 4 cores, replaced by BR042a US Biomax 88 |
BR041 |
Breast cancer tissue array with HER2 IHC control, including TNM and pathology grade, 4 cases 4 cores, replaced by BR042a |
US Biomax |
|
88€ |
|
Pub |
T291a Myeloma tissue array with normal tissue as control, 6 cases 24 cores, replacing T291; ihc Anti-actin US Biomax 114 |
T291a |
Myeloma tissue array with normal tissue as control, 6 cases 24 cores, replacing T291; ihc Anti-actin |
US Biomax |
|
114€ |
|
Pub |
BC04119 Lung adenocarcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 30 cases 40 cores, replaced by BC04119b US Biomax 231 |
BC04119 |
Lung adenocarcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 30 cases 40 cores, replaced by BC04119b |
US Biomax |
|
231€ |
|
Pub |
BR243a Breast invasive ductal carcinoma tissue array with matched adjacent normal breast tissue, including TNM and pathology grade, 6 cases 24 cores, replacing BR243 US Biomax 99 |
BR243a |
Breast invasive ductal carcinoma tissue array with matched adjacent normal breast tissue, including TNM and pathology grade, 6 cases 24 cores, replacing BR243 |
US Biomax |
|
99€ |
|
Pub |
BR246a Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 12 cases 24 cores, replacing BR246 US Biomax 99 |
BR246a |
Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 12 cases 24 cores, replacing BR246 |
US Biomax |
|
99€ |
|
Pub |
BN481 Multiple human normal organ (12 type) tissue microarray, 24 cases 48 cores US Biomax 160 |
BN481 |
Multiple human normal organ (12 type) tissue microarray, 24 cases 48 cores |
US Biomax |
|
160€ |
|
Pub |
T203a Lymphatic tissue tumor test tissue array, with normal control tissue, 12 cases 24 cores, replacing T203; ihc Anti-Actin confirmed US Biomax 90 |
T203a |
Lymphatic tissue tumor test tissue array, with normal control tissue, 12 cases 24 cores, replacing T203; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
BC02023 Esophagus squamous cell carcinoma (combination of adjacent and normal) tissue array, 18 cases 54cores, replaced by ES722 US Biomax 160 |
BC02023 |
Esophagus squamous cell carcinoma (combination of adjacent and normal) tissue array, 18 cases 54cores, replaced by ES722 |
US Biomax |
|
160€ |
|
Pub |
CO725 Colon poorly differentiated adenocarcinoma and adjacent normal tissue array, with stage and grade info, 24 cases 72 cores, replacing BS05041 US Biomax 231 |
CO725 |
Colon poorly differentiated adenocarcinoma and adjacent normal tissue array, with stage and grade info, 24 cases 72 cores, replacing BS05041 |
US Biomax |
|
231€ |
|
Pub |
ME1004 Malignant melanoma, metastatic malignant melanoma and nevus tissue array, including TNM, 100 cases 100 cores, replacing ME1003 US Biomax 314 |
ME1004 |
Malignant melanoma, metastatic malignant melanoma and nevus tissue array, including TNM, 100 cases 100 cores, replacing ME1003 |
US Biomax |
|
314€ |
|
Pub |
BC110118 Ovarian cancer tissue array, including TNM and pathology grade, 72 cases 72 cores, replacing BC11012 US Biomax 231 |
BC110118 |
Ovarian cancer tissue array, including TNM and pathology grade, 72 cases 72 cores, replacing BC11012 |
US Biomax |
|
231€ |
|
Pub |
T002 Endocrine organ cancer test tissue array, with normal tissue as control, including TNM and clinical stage, 6 cases 24 cores US Biomax 88 |
T002 |
Endocrine organ cancer test tissue array, with normal tissue as control, including TNM and clinical stage, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
LN801 Normal lymphatic (lymph node, thymus, spleen, tonsil and appendix) tissue array, 80 cases 80 cores, replaced by LN802 US Biomax 231 |
LN801 |
Normal lymphatic (lymph node, thymus, spleen, tonsil and appendix) tissue array, 80 cases 80 cores, replaced by LN802 |
US Biomax |
|
231€ |
|
Pub |
BR802 Breast cancer tissue array, with matched or unmatched adjacent normal tissue array, 40 cases 80 cores, no overlaps with BR801, BR803 and BR1001, replaced by BR802b US Biomax 231 |
BR802 |
Breast cancer tissue array, with matched or unmatched adjacent normal tissue array, 40 cases 80 cores, no overlaps with BR801, BR803 and BR1001, replaced by BR802b |
US Biomax |
|
231€ |
|
Pub |
BM483 Bone marrow tumor and adjacent normal tissue array, including TNM and pathology grade, 24 cases 48 cores, replacing BM482 US Biomax 266 |
BM483 |
Bone marrow tumor and adjacent normal tissue array, including TNM and pathology grade, 24 cases 48 cores, replacing BM482 |
US Biomax |
|
266€ |
|
Pub |
T113a Ovary cancer test tissue array with normal ovary tissue, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores, replacing T113; ihc Anti-Actin confirmed US Biomax 90 |
T113a |
Ovary cancer test tissue array with normal ovary tissue, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores, replacing T113; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
BC000120 Multi organ carcinoma tissue array, including TNM, clinical stage and pathology grade, 200 cases 200 cores US Biomax 456 |
BC000120 |
Multi organ carcinoma tissue array, including TNM, clinical stage and pathology grade, 200 cases 200 cores |
US Biomax |
|
456€ |
|
Pub |
BR1005a Breast cancer and matched metastatic carcinoma of lymph node tissue array, including TNM, clinical stage and pathology grade, 50 cases 100 cores, replacing BR1005; ihc Anti-Actin confirmed US Biomax 296 |
BR1005a |
Breast cancer and matched metastatic carcinoma of lymph node tissue array, including TNM, clinical stage and pathology grade, 50 cases 100 cores, replacing BR1005; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
MC962 Multiple carcinoma tissue array with matched normal organ tissue, 58 cases 96 cores US Biomax 0 |
MC962 |
Multiple carcinoma tissue array with matched normal organ tissue, 58 cases 96 cores |
US Biomax |
|
0€ |
|
Pub |
LC10012 Lung non small cell cancer tissue array, with adjacent tissue and normal tissue, including TNM and pathology grade, 50 cases 100 cores, replacing LC1006 US Biomax 266 |
LC10012 |
Lung non small cell cancer tissue array, with adjacent tissue and normal tissue, including TNM and pathology grade, 50 cases 100 cores, replacing LC1006 |
US Biomax |
|
266€ |
|
Pub |
BC07011 Kidney carcinoma (multi tissue combined panel) tissue array, 23 cases 63 cores, replaced by BC07013 US Biomax 160 |
BC07011 |
Kidney carcinoma (multi tissue combined panel) tissue array, 23 cases 63 cores, replaced by BC07013 |
US Biomax |
|
160€ |
|
Pub |
T081 Breast cancer test tissue array, with normal breast tissues as control, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replaced by T085 US Biomax 88 |
T081 |
Breast cancer test tissue array, with normal breast tissues as control, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replaced by T085 |
US Biomax |
|
88€ |
|
Pub |
TH809a Thyroid metastatic carcinoma tissue array with normal thyroid tissue as control, 40 cases 80 cores, replacing TH809; ihc Anti-Actin confirmed US Biomax 296 |
TH809a |
Thyroid metastatic carcinoma tissue array with normal thyroid tissue as control, 40 cases 80 cores, replacing TH809; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
GL806a Brain glioblastoma multiforme(GBM) tissue array, 40 cases 80 cores, replacing GL806; ihc Anti-Actin confirmed US Biomax 258 |
GL806a |
Brain glioblastoma multiforme(GBM) tissue array, 40 cases 80 cores, replacing GL806; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
BO244 Human normal bone and osteosarcoma tissue array, 12 cases 24 cores, replacing BO243 US Biomax 100 |
BO244 |
Human normal bone and osteosarcoma tissue array, 12 cases 24 cores, replacing BO243 |
US Biomax |
|
100€ |
|
Pub |
PR956 Prostate cancer tissue array with matched normal adjacent tissue and metastatic bones, with TNM, Gleason scores, PSA level and survival data, 40 cases 95 cores, replacing PR955; ihc Anti-Actin confir US Biomax 487 |
PR956 |
Prostate cancer tissue array with matched normal adjacent tissue and metastatic bones, with TNM, Gleason scores, PSA level and survival data, 40 cases 95 cores, replacing PR955; ihc Anti-Actin confir |
US Biomax |
|
487€ |
|
Pub |
CO806 Colon normal adjacent tissue array, replacing BN05012, 80 cases 80 cores US Biomax 231 |
CO806 |
Colon normal adjacent tissue array, replacing BN05012, 80 cases 80 cores |
US Biomax |
|
231€ |
|
Pub |
SO1001 Peripheral nerve disease spectrum (peripheroneural cancer progression) tissue array, 50 cases 100 cores US Biomax 266 |
SO1001 |
Peripheral nerve disease spectrum (peripheroneural cancer progression) tissue array, 50 cases 100 cores |
US Biomax |
|
266€ |
|
Pub |
BR808 Tissue array of multiple types of breast cancer and normal breast tissue, 80 cases 80 cores, replaced by BR8018 US Biomax 231 |
BR808 |
Tissue array of multiple types of breast cancer and normal breast tissue, 80 cases 80 cores, replaced by BR8018 |
US Biomax |
|
231€ |
|
Pub |
BN03011 Normal liver tissue array (multi sites), 20 cases 63 cores, replaced by LVN801 US Biomax 160 |
BN03011 |
Normal liver tissue array (multi sites), 20 cases 63 cores, replaced by LVN801 |
US Biomax |
|
160€ |
|
Pub |
T142a Pancreas tumor test tissue array, including TNM and pathology grade, 12 cases 24 cores, replacing T142; ihc Anti-Actin confirmed US Biomax 90 |
T142a |
Pancreas tumor test tissue array, including TNM and pathology grade, 12 cases 24 cores, replacing T142; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
PR243 Prostate cancer and normal tissue array, with stage and grade info, 12 cases 24 cores, replacing PR241 US Biomax 88 |
PR243 |
Prostate cancer and normal tissue array, with stage and grade info, 12 cases 24 cores, replacing PR241 |
US Biomax |
|
88€ |
|
Pub |
BR962 Breast cancer array with normal and other non malignant breast tissues, with AR, ER, PR, Her 2 (neu) IHC results, 48 cases 96 cores, replacing BR961, BR701 US Biomax 231 |
BR962 |
Breast cancer array with normal and other non malignant breast tissues, with AR, ER, PR, Her 2 (neu) IHC results, 48 cases 96 cores, replacing BR961, BR701 |
US Biomax |
|
231€ |
|
Pub |
TE242 Testis cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 12 cases 24 cores, replacing TE241 US Biomax 88 |
TE242 |
Testis cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 12 cases 24 cores, replacing TE241 |
US Biomax |
|
88€ |
|
Pub |
GIST802 Multiple organ stromal tumor tissue array (containing stomach, colon, rectum, small intestine, cardia, pancreas, retroperitoneum stroma and pelvic cavity), 80 cases 80 cores, no overlapping with GIST8 US Biomax 296 |
GIST802 |
Multiple organ stromal tumor tissue array (containing stomach, colon, rectum, small intestine, cardia, pancreas, retroperitoneum stroma and pelvic cavity), 80 cases 80 cores, no overlapping with GIST8 |
US Biomax |
|
296€ |
|
Pub |
BC01011 Stomach carcinoma (multi tissue combined panel) tissue array, 24 cases 72 cores, replaced by ST721 US Biomax 160 |
BC01011 |
Stomach carcinoma (multi tissue combined panel) tissue array, 24 cases 72 cores, replaced by ST721 |
US Biomax |
|
160€ |
|
Pub |
PR633 Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 63 cases 63 cores, replacing PR8010; ihc Anti-Actin confirmed US Biomax 296 |
PR633 |
Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 63 cases 63 cores, replacing PR8010; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
OV1003 Ovarian cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 231 |
OV1003 |
Ovarian cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores |
US Biomax |
|
231€ |
|
Pub |
HN811 Head and Neck tumor and normal tissue array, including TNM, clinical stage and pathology grade, 27 cases 81 cores, replacing BC34111 US Biomax 266 |
HN811 |
Head and Neck tumor and normal tissue array, including TNM, clinical stage and pathology grade, 27 cases 81 cores, replacing BC34111 |
US Biomax |
|
266€ |
|
Pub |
BC08014 Breast cancer (multiple types of breast cancer) tissue array, 63 cases 63 cores, replaced by BR8018 US Biomax 160 |
BC08014 |
Breast cancer (multiple types of breast cancer) tissue array, 63 cases 63 cores, replaced by BR8018 |
US Biomax |
|
160€ |
|
Pub |
T088 Breast cancer tissue array, with normal tissue as control, including TNM and pathology grade, 6 cases 24 cores, replacing T085 US Biomax 88 |
T088 |
Breast cancer tissue array, with normal tissue as control, including TNM and pathology grade, 6 cases 24 cores, replacing T085 |
US Biomax |
|
88€ |
|
Pub |
TMA2401 High density multiple organ (top 4) cancer tissue array (240 cores) US Biomax 456 |
TMA2401 |
High density multiple organ (top 4) cancer tissue array (240 cores) |
US Biomax |
|
456€ |
|
Pub |
ES801 Esophagus cancer, with matched normal adjacent tissue array, 40 cases 80 cores, replaced by ES8010 US Biomax 231 |
ES801 |
Esophagus cancer, with matched normal adjacent tissue array, 40 cases 80 cores, replaced by ES8010 |
US Biomax |
|
231€ |
|
Pub |
AC451 Multiple organ condyloma acuminatum tissue array, 45 cases 45 cores US Biomax 331 |
AC451 |
Multiple organ condyloma acuminatum tissue array, 45 cases 45 cores |
US Biomax |
|
331€ |
|
Pub |
ME804 Malignant melanoma tissue array, including TNM and clinical stage, 80 cases 80 cores, replacing ME801 US Biomax 266 |
ME804 |
Malignant melanoma tissue array, including TNM and clinical stage, 80 cases 80 cores, replacing ME801 |
US Biomax |
|
266€ |
|
Pub |
T032a Liver tumor tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T032; ihc Anti-Actin confirmed US Biomax 90 |
T032a |
Liver tumor tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T032; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
AMS542 Mouse(KM strain) normal tissue array, cover 22 organs anatomic sites, 3 cases 54 cores US Biomax 225 |
AMS542 |
Mouse(KM strain) normal tissue array, cover 22 organs anatomic sites, 3 cases 54 cores |
US Biomax |
|
225€ |
|
Pub |
PA805 Pancreatic cancer tissue array, with adjacent normal tissue and normal tissue, including TNM and pathology grade, 80 cases 80 cores, replacing PA802 US Biomax 266 |
PA805 |
Pancreatic cancer tissue array, with adjacent normal tissue and normal tissue, including TNM and pathology grade, 80 cases 80 cores, replacing PA802 |
US Biomax |
|
266€ |
|
Pub |
NHL482 Lymphoma tissue array, 48 cases 48 cores, replacing NHL481 US Biomax 189 |
NHL482 |
Lymphoma tissue array, 48 cases 48 cores, replacing NHL481 |
US Biomax |
|
189€ |
|
Pub |
T045c Lung cancer test tissue array, with normal control tissue, including TNM and pathology grade, 12 cases 24 cores, replacing T045; ihc Anti-Actin confirmed US Biomax 90 |
T045c |
Lung cancer test tissue array, with normal control tissue, including TNM and pathology grade, 12 cases 24 cores, replacing T045; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T194 Prostate cancer test tissue array, with normal control tissue, including TNM and pathology grade, 12 cases 24 cores, replaced by T195 US Biomax 88 |
T194 |
Prostate cancer test tissue array, with normal control tissue, including TNM and pathology grade, 12 cases 24 cores, replaced by T195 |
US Biomax |
|
88€ |
|
Pub |
PR803 Prostate cancer tissue array with unmatched normal prostate tissue, 80 cases 80 cores, replacing PR801 US Biomax 231 |
PR803 |
Prostate cancer tissue array with unmatched normal prostate tissue, 80 cases 80 cores, replacing PR801 |
US Biomax |
|
231€ |
|
Pub |
IC03001 Liver tissue, type B hepatitis and hepatic cirrhosis tissue array, 80 cases 80 cores, replaced by LV805 US Biomax 231 |
IC03001 |
Liver tissue, type B hepatitis and hepatic cirrhosis tissue array, 80 cases 80 cores, replaced by LV805 |
US Biomax |
|
231€ |
|
Pub |
T0011 Multiple organ cancer test tissue array, with normal tissue, including TNM and pathology grade, 6 cases 24 cores US Biomax 88 |
T0011 |
Multiple organ cancer test tissue array, with normal tissue, including TNM and pathology grade, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
BR8014 Breast cancer and normal tissue array, including TNM, clinical stage and pathology grade, 40 cases 80 cores, replacing BR8012 US Biomax 231 |
BR8014 |
Breast cancer and normal tissue array, including TNM, clinical stage and pathology grade, 40 cases 80 cores, replacing BR8012 |
US Biomax |
|
231€ |
|
Pub |
CO1004 Colon carcinoma tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores US Biomax 231 |
CO1004 |
Colon carcinoma tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores |
US Biomax |
|
231€ |
|
Pub |
BR10010 Breast cancer and matched metastatic carcinoma tissue array, including TNM and pathology grade, 50 cases 100 cores, replacing BR1004 US Biomax 314 |
BR10010 |
Breast cancer and matched metastatic carcinoma tissue array, including TNM and pathology grade, 50 cases 100 cores, replacing BR1004 |
US Biomax |
|
314€ |
|
Pub |
BC050112 Colon metastatic carcinoma tissue array, 23 cases 63 cores, replaced by CO726 US Biomax 231 |
BC050112 |
Colon metastatic carcinoma tissue array, 23 cases 63 cores, replaced by CO726 |
US Biomax |
|
231€ |
|
Pub |
OV803a Ovary cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing OV803; ihc Anti-Actin confirmed US Biomax 258 |
OV803a |
Ovary cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing OV803; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
LC723 Lung cancer and adjacent normal tissue array, with TNM and grade info, 24 cases 72 cores, replacing BS04071 US Biomax 231 |
LC723 |
Lung cancer and adjacent normal tissue array, with TNM and grade info, 24 cases 72 cores, replacing BS04071 |
US Biomax |
|
231€ |
|
Pub |
BR243e Breast cancer tissue array with adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replacing BR243a; ihc Anti-Actin confirmed US Biomax 90 |
BR243e |
Breast cancer tissue array with adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replacing BR243a; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
MNO341 Antibody cross reactivity testing tissue array, 33 cases 34 cores US Biomax 118 |
MNO341 |
Antibody cross reactivity testing tissue array, 33 cases 34 cores |
US Biomax |
|
118€ |
|
Pub |
BE01014 Multiple organ, normal fetus tissue array, 26 cases 78 cores US Biomax 189 |
BE01014 |
Multiple organ, normal fetus tissue array, 26 cases 78 cores |
US Biomax |
|
189€ |
|
Pub |
GL803 Brain tumor tissue array of glioblastoma, astrocytoma, ependymoma, oligo astrocytoma, medulloblastoma and oligodendroglioma, 78 cases 80 cores, replacing BS17015 US Biomax 266 |
GL803 |
Brain tumor tissue array of glioblastoma, astrocytoma, ependymoma, oligo astrocytoma, medulloblastoma and oligodendroglioma, 78 cases 80 cores, replacing BS17015 |
US Biomax |
|
266€ |
|
Pub |
BC03011 Liver carcinoma (multi tissue combined panel) tissue array, 63 cases 63 cores, replaced by LV8010 US Biomax 160 |
BC03011 |
Liver carcinoma (multi tissue combined panel) tissue array, 63 cases 63 cores, replaced by LV8010 |
US Biomax |
|
160€ |
|
Pub |
ST1003 Stomach cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores US Biomax 231 |
ST1003 |
Stomach cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores |
US Biomax |
|
231€ |
|
Pub |
PR951 Prostate adenocarcinoma tissue array with matched normal adjacent tissue and metastatic bones, 40 cases 95 cores, with TNM and Gleason scores, replaced by PR952; ihc Anti-PCNA confirmed US Biomax 487 |
PR951 |
Prostate adenocarcinoma tissue array with matched normal adjacent tissue and metastatic bones, 40 cases 95 cores, with TNM and Gleason scores, replaced by PR952; ihc Anti-PCNA confirmed |
US Biomax |
|
487€ |
|
Pub |
CO802a Colon cancer tissue array with adjacent normal colon tissue, including TNM and clinical stage, 80 cases 80 cores, replacing CO802; ihc Anti-Actin confirmed US Biomax 258 |
CO802a |
Colon cancer tissue array with adjacent normal colon tissue, including TNM and clinical stage, 80 cases 80 cores, replacing CO802; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
BS36011 Cartilages sarcoma (Chondrosarcoma) tissue array, 25 cases 75 cores, replaced by OS803 US Biomax 266 |
BS36011 |
Cartilages sarcoma (Chondrosarcoma) tissue array, 25 cases 75 cores, replaced by OS803 |
US Biomax |
|
266€ |
|
Pub |
T006 Multiple organ cancer and normal tissue array, including TNM and pathology grade, 6 cases 24 cores US Biomax 88 |
T006 |
Multiple organ cancer and normal tissue array, including TNM and pathology grade, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
PA241b Pancreas adenocarcinoma tissue array with matched adjacent normal pancreas tissue, including TNM and pathology grade, 6 cases 24 cores, replacing PA241 US Biomax 99 |
PA241b |
Pancreas adenocarcinoma tissue array with matched adjacent normal pancreas tissue, including TNM and pathology grade, 6 cases 24 cores, replacing PA241 |
US Biomax |
|
99€ |
|
Pub |
BR804 Breast tumor tissue array, with matched tumor and adjacent normal tissue, replacing BR801, 40 cases 80 cores US Biomax 231 |
BR804 |
Breast tumor tissue array, with matched tumor and adjacent normal tissue, replacing BR801, 40 cases 80 cores |
US Biomax |
|
231€ |
|
Pub |
T124 Bladder cancer test tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T122; ihc Anti-Actin confirmed US Biomax 90 |
T124 |
Bladder cancer test tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T122; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
UT1001 Endometrial cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 266 |
UT1001 |
Endometrial cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores |
US Biomax |
|
266€ |
|
Pub |
BR1009 Breast cancer tissue array for antibody screening , including TNM and pathology grade, 50 cases 100 cores US Biomax 266 |
BR1009 |
Breast cancer tissue array for antibody screening , including TNM and pathology grade, 50 cases 100 cores |
US Biomax |
|
266€ |
|
Pub |
T386 Malignant melanoma test tissue array, with normal skin tissue, including TNM and clinical stage, 6 cases 24 cores, replacing T385 US Biomax 88 |
T386 |
Malignant melanoma test tissue array, with normal skin tissue, including TNM and clinical stage, 6 cases 24 cores, replacing T385 |
US Biomax |
|
88€ |
|
Pub |
BC05118a Colon cancer tissue array with matched adjacent normal colon tissue, including TNM, clinical stage and pathology grade, 50 cases 100 cores, replacing BC05118; ihc Anti-Actin confirmed US Biomax 296 |
BC05118a |
Colon cancer tissue array with matched adjacent normal colon tissue, including TNM, clinical stage and pathology grade, 50 cases 100 cores, replacing BC05118; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
OS802 Osteosarcoma and chondrosarcoma tissue array, with stage, grade and TNM data, 80 cases 80 cores, replacing BC26111 US Biomax 266 |
OS802 |
Osteosarcoma and chondrosarcoma tissue array, with stage, grade and TNM data, 80 cases 80 cores, replacing BC26111 |
US Biomax |
|
266€ |
|
Pub |
HN483 Multiple head and neck cancer with normal tissue array, including TNM and pathology grade, 48 cases 48 cores, replacing HN482 US Biomax 160 |
HN483 |
Multiple head and neck cancer with normal tissue array, including TNM and pathology grade, 48 cases 48 cores, replacing HN482 |
US Biomax |
|
160€ |
|
Pub |
BC07014a Kidney cancer tissue array, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing BC07014; ihc Anti-Actin confirmed US Biomax 185 |
BC07014a |
Kidney cancer tissue array, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing BC07014; ihc Anti-Actin confirmed |
US Biomax |
|
185€ |
|
Pub |
BR701 Breast cancer tissue array, 70 cases 70 cores, with TNM data plus ER, PR and Her 2 (C erbB 2, neu< em>) IHC results, replaced by BR962 US Biomax 231 |
BR701 |
Breast cancer tissue array, 70 cases 70 cores, with TNM data plus ER, PR and Her 2 (C erbB 2, neu< em>) IHC results, replaced by BR962 |
US Biomax |
|
231€ |
|
Pub |
T085 Breast cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replaced by T088 US Biomax 88 |
T085 |
Breast cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replaced by T088 |
US Biomax |
|
88€ |
|
Pub |
MC485 Multiple organ tumor tissue array, including TNM, clinical stage and pathology grade, 24 cases 48 cores US Biomax 231 |
MC485 |
Multiple organ tumor tissue array, including TNM, clinical stage and pathology grade, 24 cases 48 cores |
US Biomax |
|
231€ |
|
Pub |
BC04013 Non small cell lung carcinoma tissue array, 63 cases 63 core, replaced by LC806 US Biomax 160 |
BC04013 |
Non small cell lung carcinoma tissue array, 63 cases 63 core, replaced by LC806 |
US Biomax |
|
160€ |
|
Pub |
BR2085c Breast cancer tissue array, with normal tissue and adjacent normal tissue, including TNM and pathology grade, 188 cases 208 cores, replacing BR2085a US Biomax 456 |
BR2085c |
Breast cancer tissue array, with normal tissue and adjacent normal tissue, including TNM and pathology grade, 188 cases 208 cores, replacing BR2085a |
US Biomax |
|
456€ |
|
Pub |
BR951 Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER PR p53 IHC results and survival data, 31 cases 95 cores, to be replaced by BR95 US Biomax 456 |
BR951 |
Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER PR p53 IHC results and survival data, 31 cases 95 cores, to be replaced by BR95 |
US Biomax |
|
456€ |
|
Pub |
NHL802a Non-Hodgkin's lymphoma tissue array, 42 cases 80 cores, replacing NHL802; ihc Anti-Actin confirmed US Biomax 267 |
NHL802a |
Non-Hodgkin's lymphoma tissue array, 42 cases 80 cores, replacing NHL802; ihc Anti-Actin confirmed |
US Biomax |
|
267€ |
|
Pub |
BN114 Multiple normal human organ tissue array, 48 cases 48 cores US Biomax 189 |
BN114 |
Multiple normal human organ tissue array, 48 cases 48 cores |
US Biomax |
|
189€ |
|
Pub |
T175 Brain tumor tissue array with normal brain tissue as control, including pathology grade, 12 cases 24 cores, replacing T172; ihc Anti-Actin confirmed US Biomax 105 |
T175 |
Brain tumor tissue array with normal brain tissue as control, including pathology grade, 12 cases 24 cores, replacing T172; ihc Anti-Actin confirmed |
US Biomax |
|
105€ |
|
Pub |
SK801 Skin cancer tissue array, with matched or unmatched adjacent normal tissue, 80 cases 73 cores, replaced by SK801b US Biomax 278 |
SK801 |
Skin cancer tissue array, with matched or unmatched adjacent normal tissue, 80 cases 73 cores, replaced by SK801b |
US Biomax |
|
278€ |
|
Pub |
BR801 Breast tumor tissue array, with matched tumor and adjacent normal tissue, 40 cases 80 cores, replaced by BR804 US Biomax 231 |
BR801 |
Breast tumor tissue array, with matched tumor and adjacent normal tissue, 40 cases 80 cores, replaced by BR804 |
US Biomax |
|
231€ |
|
Pub |
OV701 Ovary cancer tissue array, with adjacent normal tissue, including TNM, clinical stage and pathology grade, 70 cases 70 cores, replacing BC111110; ihc Anti-Actin confirmed US Biomax 228 |
OV701 |
Ovary cancer tissue array, with adjacent normal tissue, including TNM, clinical stage and pathology grade, 70 cases 70 cores, replacing BC111110; ihc Anti-Actin confirmed |
US Biomax |
|
228€ |
|
Pub |
BR243 Breast cancer and adjacent normal tissue array, 6 cases 24 cores, replaced by BR243a US Biomax 88 |
BR243 |
Breast cancer and adjacent normal tissue array, 6 cases 24 cores, replaced by BR243a |
US Biomax |
|
88€ |
|
Pub |
T042 Lung cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replaced by T044 US Biomax 88 |
T042 |
Lung cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replaced by T044 |
US Biomax |
|
88€ |
|
Pub |
CR1003 Cervix cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores US Biomax 231 |
CR1003 |
Cervix cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores |
US Biomax |
|
231€ |
|
Pub |
LC726a Lung cancer tissue array, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing LC726; ihc Anti-Actin confirmed US Biomax 228 |
LC726a |
Lung cancer tissue array, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing LC726; ihc Anti-Actin confirmed |
US Biomax |
|
228€ |
|
Pub |
BR246 Breast cancer tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replaced by BR246a US Biomax 88 |
BR246 |
Breast cancer tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replaced by BR246a |
US Biomax |
|
88€ |
|
Pub |
BCN801 Multiple organ cancer with adjacent tissue combined panel tissue array, 48 cases 80 cores US Biomax 231 |
BCN801 |
Multiple organ cancer with adjacent tissue combined panel tissue array, 48 cases 80 cores |
US Biomax |
|
231€ |
|
Pub |
ART661 Rat(Wistar strain) normal tissue array, covering all major organs, non overlapping with ART662, 22 cases 66 cores US Biomax 225 |
ART661 |
Rat(Wistar strain) normal tissue array, covering all major organs, non overlapping with ART662, 22 cases 66 cores |
US Biomax |
|
225€ |
|
Pub |
MBN481 Multiple organ normal tissue array, 48 cases 48 cores; ihc Anti-Actin confirmed US Biomax 185 |
MBN481 |
Multiple organ normal tissue array, 48 cases 48 cores; ihc Anti-Actin confirmed |
US Biomax |
|
185€ |
|
Pub |
ES1202 Esophageal tumor tissue array, with stage, grade and matched adjacent tissue, 60 cases 120 cores, replacing ES1201 US Biomax 278 |
ES1202 |
Esophageal tumor tissue array, with stage, grade and matched adjacent tissue, 60 cases 120 cores, replacing ES1201 |
US Biomax |
|
278€ |
|
Pub |
OV20814 Ovary adenocarcinoma tissue array, including TNM and pathology grade, 208 cases 208 cores, replacing OV2084 US Biomax 558 |
OV20814 |
Ovary adenocarcinoma tissue array, including TNM and pathology grade, 208 cases 208 cores, replacing OV2084 |
US Biomax |
|
558€ |
|
Pub |
CO724 Colon moderately differentiated adenocarcinoma and adjacent normal tissue array, with stage and grade info, 24 cases 72 cores, replacing BS05031 US Biomax 278 |
CO724 |
Colon moderately differentiated adenocarcinoma and adjacent normal tissue array, with stage and grade info, 24 cases 72 cores, replacing BS05031 |
US Biomax |
|
278€ |
|
Pub |
ME1003 Malignant melanoma, metastatic malignant melanoma and benign nevus tissue array, including TNM and clinical stage, 100 cases 100 cores, replaced by ME1004 US Biomax 266 |
ME1003 |
Malignant melanoma, metastatic malignant melanoma and benign nevus tissue array, including TNM and clinical stage, 100 cases 100 cores, replaced by ME1004 |
US Biomax |
|
266€ |
|
Pub |
BS17016a Brain glioblastoma tissue array, including pathology grade, 40 cases 80 cores, replacing BS17016; ihc Anti-Actin confirmed US Biomax 267 |
BS17016a |
Brain glioblastoma tissue array, including pathology grade, 40 cases 80 cores, replacing BS17016; ihc Anti-Actin confirmed |
US Biomax |
|
267€ |
|
Pub |
BC11011 Ovarian carcinoma (multi tissue combined panel) tissue array (replaced by OV802), 70 cases 72 cores US Biomax 160 |
BC11011 |
Ovarian carcinoma (multi tissue combined panel) tissue array (replaced by OV802), 70 cases 72 cores |
US Biomax |
|
160€ |
|
Pub |
T001a Embryonal tumor test tissue array, with normal tissue as control, including TNM and clinical stage, 6 cases 24 cores, replacing T001; ihc Anti-Actin confirmed US Biomax 90 |
T001a |
Embryonal tumor test tissue array, with normal tissue as control, including TNM and clinical stage, 6 cases 24 cores, replacing T001; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
PA2072 Pancreas cancer tissue array, with normal tissue, including TNM and pathology grade, 69 cases 207 cores, replacing PA207 US Biomax 456 |
PA2072 |
Pancreas cancer tissue array, with normal tissue, including TNM and pathology grade, 69 cases 207 cores, replacing PA207 |
US Biomax |
|
456€ |
|
Pub |
BR8018 Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 80 cases 80 cores, replacing BR808, BC08014 US Biomax 266 |
BR8018 |
Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 80 cases 80 cores, replacing BR808, BC08014 |
US Biomax |
|
266€ |
|
Pub |
BM482 Multiple myeloma tissue microarray with normal tissue as control, 24 cases 48 cores, replaced by BM483 US Biomax 397 |
BM482 |
Multiple myeloma tissue microarray with normal tissue as control, 24 cases 48 cores, replaced by BM483 |
US Biomax |
|
397€ |
|
Pub |
LV8010 Liver cancer and normal tissue array, with stage and grade info, 80 cases 80 cores, replacing BC03011; ihc Anti-Actin confirmed US Biomax 296 |
LV8010 |
Liver cancer and normal tissue array, with stage and grade info, 80 cases 80 cores, replacing BC03011; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
BR1004 Tissue array of breast carcinoma and matched metastasis in lymph nodes tissue arrays, 50 cases 100 cores, replaced by BR10010 US Biomax 314 |
BR1004 |
Tissue array of breast carcinoma and matched metastasis in lymph nodes tissue arrays, 50 cases 100 cores, replaced by BR10010 |
US Biomax |
|
314€ |
|
Pub |
T381 Malignant melanoma test tissue array, with normal skin control tissue, including TNM and clinical stage, 6 cases 24 cores, replaced by T385 US Biomax 88 |
T381 |
Malignant melanoma test tissue array, with normal skin control tissue, including TNM and clinical stage, 6 cases 24 cores, replaced by T385 |
US Biomax |
|
88€ |
|
Pub |
BS03011 Hepatocellular carcinoma tissue array, 21 cases 63 cores, replaced by LV804 US Biomax 160 |
BS03011 |
Hepatocellular carcinoma tissue array, 21 cases 63 cores, replaced by LV804 |
US Biomax |
|
160€ |
|
Pub |
LC10011 Non small cell lung carcinoma (NSCLC) tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores US Biomax 231 |
LC10011 |
Non small cell lung carcinoma (NSCLC) tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores |
US Biomax |
|
231€ |
|
Pub |
HN241a Head and neck cancer tissue array with adjacent normal head and neck tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing HN241; ihc Anti-Actin confirmed US Biomax 90 |
HN241a |
Head and neck cancer tissue array with adjacent normal head and neck tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing HN241; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
ST808 Stomach adenocarcinoma and normal tissue array, 80 cases 80 cores, replacing BS01032 US Biomax 231 |
ST808 |
Stomach adenocarcinoma and normal tissue array, 80 cases 80 cores, replacing BS01032 |
US Biomax |
|
231€ |
|
Pub |
MNT241 Multiple tumor and normal tissue array for IHC antibody and ISH probe optimization and initial screening, 12 cases 24 cores US Biomax 77 |
MNT241 |
Multiple tumor and normal tissue array for IHC antibody and ISH probe optimization and initial screening, 12 cases 24 cores |
US Biomax |
|
77€ |
|
Pub |
OR601a Oral squamous cell cancer tissue array with adjacent normal tongue tissue, including TNM, clinical stage and pathology grade, 60 cases 60 cores, replacing OR601; ihc Anti-Actin confirmed US Biomax 258 |
OR601a |
Oral squamous cell cancer tissue array with adjacent normal tongue tissue, including TNM, clinical stage and pathology grade, 60 cases 60 cores, replacing OR601; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
MC2501 Multiple organs tumor and normal tissue array, with TNM, clinical stage and pathology grade, 250 cases 250 cores US Biomax 516 |
MC2501 |
Multiple organs tumor and normal tissue array, with TNM, clinical stage and pathology grade, 250 cases 250 cores |
US Biomax |
|
516€ |
|
Pub |
GL806 Brain glioblastoma and normal tissue array, 40 cases 80 cores, replacing GL805 US Biomax 266 |
GL806 |
Brain glioblastoma and normal tissue array, 40 cases 80 cores, replacing GL805 |
US Biomax |
|
266€ |
|
Pub |
BO243 Human normal bone and osteosarcoma tissue array, 12 cases 24 cores, replaced by BO244 US Biomax 88 |
BO243 |
Human normal bone and osteosarcoma tissue array, 12 cases 24 cores, replaced by BO244 |
US Biomax |
|
88€ |
|
Pub |
PR955 Prostate cancer tissue array with matched normal adjacent tissue and metastatic bones, with TNM, Gleason scores, PSA level and survival data, 40 cases 95 cores, replacing PR954 US Biomax 558 |
PR955 |
Prostate cancer tissue array with matched normal adjacent tissue and metastatic bones, with TNM, Gleason scores, PSA level and survival data, 40 cases 95 cores, replacing PR954 |
US Biomax |
|
558€ |
|
Pub |
ME241a Multiple malignant melanoma tissue array with adjacent normal skin tissue, including TNM and clinical stage, 12 cases 24 cores, replacing ME241; ihc Anti-Actin confirmed US Biomax 105 |
ME241a |
Multiple malignant melanoma tissue array with adjacent normal skin tissue, including TNM and clinical stage, 12 cases 24 cores, replacing ME241; ihc Anti-Actin confirmed |
US Biomax |
|
105€ |
|
Pub |
PR242a Prostate cancer tissue array with adjacent normal prostate tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing PR242; ihc Anti-Actin confirmed US Biomax 105 |
PR242a |
Prostate cancer tissue array with adjacent normal prostate tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing PR242; ihc Anti-Actin confirmed |
US Biomax |
|
105€ |
|
Pub |
BR961 Breast cancer array with normal and other non malignant breast tissues, with AR, ER, PR, Her 2 (neu) IHC results, 48 cases 96 cores, replaced by BR962 US Biomax 0 |
BR961 |
Breast cancer array with normal and other non malignant breast tissues, with AR, ER, PR, Her 2 (neu) IHC results, 48 cases 96 cores, replaced by BR962 |
US Biomax |
|
0€ |
|
Pub |
BN08013 Normal breast tissue (multi sites) array, 71 cases 72 cores, replaced by BRN801 US Biomax 160 |
BN08013 |
Normal breast tissue (multi sites) array, 71 cases 72 cores, replaced by BRN801 |
US Biomax |
|
160€ |
|
Pub |
LC1009 Lung small cell carcinoma tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 231 |
LC1009 |
Lung small cell carcinoma tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores |
US Biomax |
|
231€ |
|
Pub |
HN803a Multiple head and neck cancer tissue array with normal tissue, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing HN803; ihc Anti-Actin confirmed US Biomax 296 |
HN803a |
Multiple head and neck cancer tissue array with normal tissue, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing HN803; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
BC08013 Breast carcinoma (multi tissue combined panel) tissue array, 63 cases 63 cores, replaced by BC08014 US Biomax 160 |
BC08013 |
Breast carcinoma (multi tissue combined panel) tissue array, 63 cases 63 cores, replaced by BC08014 |
US Biomax |
|
160€ |
|
Pub |
MO1601 Mouse tissue array of liver, kidney, lung, muscle, brain, heart, stomach, spleen, 160 cases 160 cores, replacing BM01011 US Biomax 278 |
MO1601 |
Mouse tissue array of liver, kidney, lung, muscle, brain, heart, stomach, spleen, 160 cases 160 cores, replacing BM01011 |
US Biomax |
|
278€ |
|
Pub |
T087a Breast cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores, replacing T087; ihc Anti-Actin confirmed US Biomax 90 |
T087a |
Breast cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores, replacing T087; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
MC501 Multiple organs tumor and matched adjacent tissue array, 27 cases 50 cores US Biomax 160 |
MC501 |
Multiple organs tumor and matched adjacent tissue array, 27 cases 50 cores |
US Biomax |
|
160€ |
|
Pub |
ES781 Esophagus cancer tissue array, including TNM and pathology grade, 26 cases 78 cores, replacing BC02111 US Biomax 266 |
ES781 |
Esophagus cancer tissue array, including TNM and pathology grade, 26 cases 78 cores, replacing BC02111 |
US Biomax |
|
266€ |
|
Pub |
ME803a Malignant melanoma tissue array with adjacent normal skin tissue, including TNM and clinical stage, 80 cases 80 cores, replacing ME803; ihc Anti-Actin confirmed US Biomax 296 |
ME803a |
Malignant melanoma tissue array with adjacent normal skin tissue, including TNM and clinical stage, 80 cases 80 cores, replacing ME803; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
AMS541 Mouse(FBV strain) normal tissue array, cover 22 organs anatomic sites, 3 cases 54 cores US Biomax 225 |
AMS541 |
Mouse(FBV strain) normal tissue array, cover 22 organs anatomic sites, 3 cases 54 cores |
US Biomax |
|
225€ |
|
Pub |
SO751 Leiomyosarcoma and rhabdomyosarcoma tissue array, including TNM and clinical stage, 39 cases 75 cores, replacing BC24021; ihc Anti-Actin confirmed US Biomax 267 |
SO751 |
Leiomyosarcoma and rhabdomyosarcoma tissue array, including TNM and clinical stage, 39 cases 75 cores, replacing BC24021; ihc Anti-Actin confirmed |
US Biomax |
|
267€ |
|
Pub |
NHL481 Lymphoma tissue array, 48 cases 48 cores, replaced by NHL482 US Biomax 189 |
NHL481 |
Lymphoma tissue array, 48 cases 48 cores, replaced by NHL482 |
US Biomax |
|
189€ |
|
Pub |
GL2083a Brain tumor tissue array, including TNM, clinical stage and pathology grade, 208 cases 208 cores, replacing GL2083; ihc Anti-Cytokeratin (CK) confirmed US Biomax 487 |
GL2083a |
Brain tumor tissue array, including TNM, clinical stage and pathology grade, 208 cases 208 cores, replacing GL2083; ihc Anti-Cytokeratin (CK) confirmed |
US Biomax |
|
487€ |
|
Pub |
PR802 Prostate carcinoma tissue array, 80 cases 80 cores, no overlaps with PR801, replaced by PR8010 US Biomax 231 |
PR802 |
Prostate carcinoma tissue array, 80 cases 80 cores, no overlaps with PR801, replaced by PR8010 |
US Biomax |
|
231€ |
|
Pub |
BS08011 Breast infiltrating ductal carcinoma tissue array, 22 cases 63 cores, replaced by BR727 US Biomax 160 |
BS08011 |
Breast infiltrating ductal carcinoma tissue array, 22 cases 63 cores, replaced by BR727 |
US Biomax |
|
160€ |
|
Pub |
IC00011b Gastric carcinoma, gastritis with intestinal metaplasia tissue array, including TNM and pathology grade, 80 cases 80 cores, replacing IC00011 US Biomax 321 |
IC00011b |
Gastric carcinoma, gastritis with intestinal metaplasia tissue array, including TNM and pathology grade, 80 cases 80 cores, replacing IC00011 |
US Biomax |
|
321€ |
|
Pub |
BC081120 Breast cancer and adjacent normal tissue array, including TNM and pathology grade, 110 cases 110 cores, replacing BC081115 US Biomax 266 |
BC081120 |
Breast cancer and adjacent normal tissue array, including TNM and pathology grade, 110 cases 110 cores, replacing BC081115 |
US Biomax |
|
266€ |
|
Pub |
T0010 Multiple organ cancer test tissue array, with normal tissue, including TNM and pathology grade, 6 cases 24 cores US Biomax 88 |
T0010 |
Multiple organ cancer test tissue array, with normal tissue, including TNM and pathology grade, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
LM482a Lymphoma tissue array with normal lymph node tissue as control, 48 cases 48 cores, replacing LM482; ihc Anti-Actin confirmed US Biomax 320 |
LM482a |
Lymphoma tissue array with normal lymph node tissue as control, 48 cases 48 cores, replacing LM482; ihc Anti-Actin confirmed |
US Biomax |
|
320€ |
|
Pub |
BR1001 Breast cancer tissue array with matched carcinoma metastasis to lymph nodes, 50 cases 100 cores, replaced by BR1004 US Biomax 314 |
BR1001 |
Breast cancer tissue array with matched carcinoma metastasis to lymph nodes, 50 cases 100 cores, replaced by BR1004 |
US Biomax |
|
314€ |
|
Pub |
BC05011 Multiple types of colon carcinoma tissue array, 72 cases 72 cores, replaced by CO804 US Biomax 231 |
BC05011 |
Multiple types of colon carcinoma tissue array, 72 cases 72 cores, replaced by CO804 |
US Biomax |
|
231€ |
|
Pub |
ST723 Stomach poorly differentiated adenocarcinoma tissue array with adjacent normal control, stage and grade info, 24 cases 72 cores, replacing BS01042 US Biomax 231 |
ST723 |
Stomach poorly differentiated adenocarcinoma tissue array with adjacent normal control, stage and grade info, 24 cases 72 cores, replacing BS01042 |
US Biomax |
|
231€ |
|
Pub |
BR243d Breast cancer tissue array with matched adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replacing BR243c; ihc Anti-Actin confirmed US Biomax 90 |
BR243d |
Breast cancer tissue array with matched adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replacing BR243c; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
BC30013 Heart disease and normal tissue array, replacing BC30011, 18 cases 36 cores US Biomax 231 |
BC30013 |
Heart disease and normal tissue array, replacing BC30011, 18 cases 36 cores |
US Biomax |
|
231€ |
|
Pub |
T045b Lung cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T045 US Biomax 99 |
T045b |
Lung cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T045 |
US Biomax |
|
99€ |
|
Pub |
RE724 Rectal adenocarcinoma (grade 3) tissue array, with stage, TNM and grade info, 24 cases 72 cores, replacing BS06041 US Biomax 231 |
RE724 |
Rectal adenocarcinoma (grade 3) tissue array, with stage, TNM and grade info, 24 cases 72 cores, replacing BS06041 |
US Biomax |
|
231€ |
|
Pub |
MC242 Multiple cancer (12 type) tissue array, 16 cases 24 cores, replaced by MC245 US Biomax 88 |
MC242 |
Multiple cancer (12 type) tissue array, 16 cases 24 cores, replaced by MC245 |
US Biomax |
|
88€ |
|
Pub |
GL802 Glioblastoma (grade IV) tissue array, 40 cases 80 cores, replaced by GL805 US Biomax 231 |
GL802 |
Glioblastoma (grade IV) tissue array, 40 cases 80 cores, replaced by GL805 |
US Biomax |
|
231€ |
|
Pub |
BC03011 Liver carcinoma (multi-tissue combined panel) tissue array, 63 cases 63 cores, replaced by LV8010; ihc Anti-PCNA confirmed US Biomax 185 |
BC03011 |
Liver carcinoma (multi-tissue combined panel) tissue array, 63 cases 63 cores, replaced by LV8010; ihc Anti-PCNA confirmed |
US Biomax |
|
185€ |
|
Pub |
PR809 Prostate cancer and hyperplasia tissue array, with stage and grade, 40 cases 80 cores, replacing BC19019 US Biomax 266 |
PR809 |
Prostate cancer and hyperplasia tissue array, with stage and grade, 40 cases 80 cores, replacing BC19019 |
US Biomax |
|
266€ |
|
Pub |
BS26011 Osteosarcoma tissue array, 32 cases 63 cores, replaced by OS804 US Biomax 231 |
BS26011 |
Osteosarcoma tissue array, 32 cases 63 cores, replaced by OS804 |
US Biomax |
|
231€ |
|
Pub |
T005 Multiple organ cancer and normal tissue array, including TNM and pathology grade, 6 cases 24 cores US Biomax 88 |
T005 |
Multiple organ cancer and normal tissue array, including TNM and pathology grade, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
PA241 Pancreatic cancer test tissue array with self matching normal adjacent tissue, 6 cases 24 cores, replaced by PA241b US Biomax 100 |
PA241 |
Pancreatic cancer test tissue array with self matching normal adjacent tissue, 6 cases 24 cores, replaced by PA241b |
US Biomax |
|
100€ |
|
Pub |
MT801 Multiple organ cancer metastasis tissue array, 80 cases 80 cores US Biomax 266 |
MT801 |
Multiple organ cancer metastasis tissue array, 80 cases 80 cores |
US Biomax |
|
266€ |
|
Pub |
BR803a Breast cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing BR803; ihc Anti-Actin confirmed US Biomax 258 |
BR803a |
Breast cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing BR803; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
BN00015 Multiple organ normal tissue array, 47 cases 48 cores US Biomax 160 |
BN00015 |
Multiple organ normal tissue array, 47 cases 48 cores |
US Biomax |
|
160€ |
|
Pub |
BC00019 Multiple organ squamous cell carcinoma tissue array, 63 cases 63 cores US Biomax 231 |
BC00019 |
Multiple organ squamous cell carcinoma tissue array, 63 cases 63 cores |
US Biomax |
|
231€ |
|
Pub |
BS01042 Stomach adenocarcinoma (grade III) tissue array, 22 cases 63 cores, replaced by ST723 US Biomax 160 |
BS01042 |
Stomach adenocarcinoma (grade III) tissue array, 22 cases 63 cores, replaced by ST723 |
US Biomax |
|
160€ |
|
Pub |
BR1008 Breast cancer, carcinoma metastasize to lymph nodes and adjacent normal tissue array, including TNM and pathology grade, 100 cases 100 cores, replacing BC08212 US Biomax 266 |
BR1008 |
Breast cancer, carcinoma metastasize to lymph nodes and adjacent normal tissue array, including TNM and pathology grade, 100 cases 100 cores, replacing BC08212 |
US Biomax |
|
266€ |
|
Pub |
T385a Malignant melanoma test tissue array, including TNM and clinical stage, 6 cases 24 cores, replacing T385; ihc Anti-Actin confirmed US Biomax 90 |
T385a |
Malignant melanoma test tissue array, including TNM and clinical stage, 6 cases 24 cores, replacing T385; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
BS04031 Lung squamous cell carcinoma tissue array, 63 cases 64 cores, replaced by LC724 US Biomax 160 |
BS04031 |
Lung squamous cell carcinoma tissue array, 63 cases 64 cores, replaced by LC724 |
US Biomax |
|
160€ |
|
Pub |
HN482 Multiple Head & Neck cancer tissue array with normal tissue from autopsy, 48 cases 48 cores with stage and grade data, replaced by HN483 US Biomax 160 |
HN482 |
Multiple Head & Neck cancer tissue array with normal tissue from autopsy, 48 cases 48 cores with stage and grade data, replaced by HN483 |
US Biomax |
|
160€ |
|
Pub |
BR2001 Breast cancer high density tissue array, 196 cases 200 cores, replaced by BR2086 US Biomax 456 |
BR2001 |
Breast cancer high density tissue array, 196 cases 200 cores, replaced by BR2086 |
US Biomax |
|
456€ |
|
Pub |
LC813 Multiple non small cell lung carcinoma (NSCLC) and small cell lung carcinoma tissue array with normal lung tissue, 77 cases 80 cores, replacing BC04014 US Biomax 231 |
LC813 |
Multiple non small cell lung carcinoma (NSCLC) and small cell lung carcinoma tissue array with normal lung tissue, 77 cases 80 cores, replacing BC04014 |
US Biomax |
|
231€ |
|
Pub |
T084 Breast cancer test tissue array, with normal control tissue, with TNM, Grade and Stage, 12 cases 24 cores, replacing T082 US Biomax 88 |
T084 |
Breast cancer test tissue array, with normal control tissue, with TNM, Grade and Stage, 12 cases 24 cores, replacing T082 |
US Biomax |
|
88€ |
|
Pub |
MC484 Multiple organs tumor and normal adjacent tissue, replacing BC00113, 44 cases 48 cores US Biomax 160 |
MC484 |
Multiple organs tumor and normal adjacent tissue, replacing BC00113, 44 cases 48 cores |
US Biomax |
|
160€ |
|
Pub |
GL811 Brain tumor and normal tissue array, with pathology grade, 27 cases 81 cores, replacing BS17011 US Biomax 266 |
GL811 |
Brain tumor and normal tissue array, with pathology grade, 27 cases 81 cores, replacing BS17011 |
US Biomax |
|
266€ |
|
Pub |
GI101 Multiple organ gastrointestinal (GI) tract cancer metastasis tissue array, 50 cases 100 cores US Biomax 266 |
GI101 |
Multiple organ gastrointestinal (GI) tract cancer metastasis tissue array, 50 cases 100 cores |
US Biomax |
|
266€ |
|
Pub |
BN05014 Colon normal tissue array, including TNM and pathology grade of 3 cases adenocarcinoma, 24 cases 72 cores, replacing BN05011 US Biomax 160 |
BN05014 |
Colon normal tissue array, including TNM and pathology grade of 3 cases adenocarcinoma, 24 cases 72 cores, replacing BN05011 |
US Biomax |
|
160€ |
|
Pub |
BC00114 Multiple organ normal and diseased tissue array, 36 cases 60 cores US Biomax 231 |
BC00114 |
Multiple organ normal and diseased tissue array, 36 cases 60 cores |
US Biomax |
|
231€ |
|
Pub |